WO2019163731A1 - Production method for oxazolidinone compound - Google Patents
Production method for oxazolidinone compound Download PDFInfo
- Publication number
- WO2019163731A1 WO2019163731A1 PCT/JP2019/005969 JP2019005969W WO2019163731A1 WO 2019163731 A1 WO2019163731 A1 WO 2019163731A1 JP 2019005969 W JP2019005969 W JP 2019005969W WO 2019163731 A1 WO2019163731 A1 WO 2019163731A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- mol
- formula
- compound represented
- acetonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Definitions
- the present invention relates to a method for producing an oxazolidinone compound.
- Rivaroxaban ie, formula (6)
- compound (6) is one of oral anticoagulants that directly inhibits factor Xa.
- AU2004313694B includes a compound represented by formula (1) as a method for producing compound (6).
- compound (4) A method for producing rivaroxaban via the hydrochloride of a compound represented by the formula (hereinafter referred to as compound (4)) is described. Moreover, as a manufacturing method of compound (3) which is a manufacturing intermediate, specifically, compound (1) and compound (2) were reacted as a first step in a mixed solvent of ethanol and water.
- Formula (7)
- compound (7) is then cyclized using 1,1′-carbonyldiimidazole in N-methylpyrrolidone or toluene as the second step.
- compound (3) by reacting compound (3) and methylamine in ethanol to obtain compound (4) and adding hydrochloric acid to obtain hydrochloride of compound (4); and compound (4) )
- compound (6) To obtain compound (6) from the hydrochloride salt thereof.
- the present invention relates to an efficient production method in which water is not used as a solvent in the production of compound (3) which is a production intermediate of rivaroxaban useful as a pharmaceutical, and the hydrochloride of compound (4) using the same And an efficient method for producing rivaroxaban.
- Step 1 A step of reacting Compound (1) and Compound (2) in acetonitrile in the presence of trifluoromethanesulfonate
- Step 2 A step of reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole to obtain Compound (3).
- Step 2 A step of reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole to obtain Compound (3).
- Step 3 A step of obtaining a compound (4) by reacting a compound (3) with methylamine
- Step 4 A step of reacting compound (4) with hydrogen chloride to obtain hydrochloride of compound (4).
- Step 1 A step of reacting Compound (1) and Compound (2) in acetonitrile in the presence of trifluoromethanesulfonate
- Step 2 ′ reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole
- Step 3 ′ a step of reacting the mixture obtained in Step 2 ′ with methylamine to obtain compound (4)
- Step 4 A step of reacting compound (4) with hydrogen chloride to obtain hydrochloride of compound (4).
- the trifluoromethanesulfonate is any one of [1] to [4], which is zinc (II) trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate (III), or aluminum (III) trifluoromethanesulfonate. Production method.
- Step 1 will be described.
- step 1 compound (1) and compound (2) are reacted in acetonitrile in the presence of trifluoromethanesulfonate.
- trifluoromethanesulfonate examples include zinc (II) trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate (III), aluminum trifluoromethanesulfonate (III), lithium trifluoromethanesulfonate, calcium trifluoromethanesulfonate, and trifluoromethanesulfone.
- Trifluoromethanesulfonic acid metal salts such as iron (II) acid, copper (II) trifluoromethanesulfonate and bismuth (III) trifluoromethanesulfonate, and triethylsilyl trifluoromethanesulfonate, and zinc trifluoromethanesulfonate (II ), Ytterbium trifluoromethanesulfonate (III) and aluminum (III) trifluoromethanesulfonate are preferred. , Zinc trifluoromethanesulfonate (II) and trifluoromethanesulfonic acid ytterbium (III) are more preferable. Trifluoromethanesulfonate may be an anhydride or a hydrate, and a commercially available product can be used as it is.
- the amount of trifluoromethanesulfonate to be used is generally 0.01 mol to 0.20 mol, preferably 0.02 mol to 0.07 mol, per 1 mol of compound (1).
- the amount of compound (2) to be used is generally 1 mol to 1.5 mol, preferably 1.00 mol to 1.05 mol, per 1 mol of compound (1).
- the acetonitrile used in step 1 is more preferably one having a low water content.
- the compound (2) may be decomposed by water, and 1,1′-carbonyldiimidazole used in Step 2 is hydrolyzed, which is not preferable. Therefore, the water content of acetonitrile used in Step 1 is usually 0% to 0.05%, preferably 0% to 0.02%, more preferably 0% to 0.01%.
- the water content of acetonitrile can be measured by the Karl Fischer method.
- the amount of acetonitrile used may be 3 parts by weight or more with respect to 1 part by weight of the compound (1), and is usually 5 parts by weight to 20 parts by weight, preferably 7 parts by weight to 15 parts by weight.
- the reaction is carried out by mixing compound (1), compound (2), trifluoromethanesulfonate and acetonitrile.
- the mixing order of compound (1), compound (2), trifluoromethanesulfonate and acetonitrile is not particularly limited. For example, after mixing acetonitrile, compound (1) and compound (2), trifluoromethanesulfonate is mixed. The compound (1), the compound (2) and trifluoromethanesulfonate are mixed and then acetonitrile is added.
- the reaction temperature is usually in the range of 1 ° C to 80 ° C, preferably in the range of 5 ° C to 55 ° C.
- the reaction time is usually 1 to 60 hours.
- step 2 The mixture obtained in step 1 can be directly used in step 2.
- Process 2 Step 2 will be described.
- step 2 the mixture obtained in step 1 is reacted with 1,1′-carbonyldiimidazole to obtain compound (3).
- the amount of 1,1'-carbonyldiimidazole to be used is generally 1 mol-3 mol, preferably 1.0 mol-1.5 mol, per 1 mol of compound (1) used in Step 1.
- the reaction is carried out by mixing the mixture obtained in step 1 and 1,1'-carbonyldiimidazole.
- 1,1′-carbonyldiimidazole is preferably added to the mixture obtained in Step 1.
- the entire amount of 1,1′-carbonyldiimidazole may be added all at once, or 1,1′-carbonyldiimidazole may be added. May be divided and added in multiple portions.
- the addition is usually performed within a range of 1 ° C to 80 ° C, preferably within a range of 5 ° C to 55 ° C.
- the reaction temperature is usually in the range of 1 ° C to 80 ° C, preferably in the range of 40 ° C to 80 ° C.
- the reaction time is usually 1 minute to 10 hours.
- the compound (3) can be precipitated and isolated by mixing the reaction mixture and a poor solvent.
- the poor solvent examples include hydrocarbon solvents such as heptane, toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; ether solvents such as diisopropyl ether and methyl tert-butyl ether; alcohol solvents such as methanol, ethanol and isopropyl alcohol; And toluene, and toluene, methanol or ethanol is preferably used.
- hydrocarbon solvents such as heptane, toluene and xylene
- halogenated hydrocarbon solvents such as monochlorobenzene
- ether solvents such as diisopropyl ether and methyl tert-butyl ether
- alcohol solvents such as methanol, ethanol and isopropyl alcohol
- toluene, and toluene, methanol or ethanol is preferably used.
- the amount of the poor solvent used is usually 2 to 20 parts by weight, preferably 5 to 15 parts by weight, based on 1 part by weight of the compound (1) used in Step 1.
- the mixing is usually performed within a range of 1 ° C to 60 ° C, preferably within a range of 20 ° C to 60 ° C. From the viewpoint of operability, it is preferable to carry out by adding a poor solvent to the reaction mixture.
- the compound (3) is usually precipitated as crystals by the mixing.
- a seed crystal of the compound (3) may be added as necessary.
- the amount added is 0.001 parts by weight to 0.01 parts by weight with respect to 1 part by weight of the compound (1) used in Step 1, and the addition is usually 1 ° C. to 70 ° C. Is preferably within the range of 20 ° C to 60 ° C.
- Crystals are precipitated by mixing the reaction mixture with a poor solvent and, if necessary, seed crystals, usually at ⁇ 20 ° C. to 60 ° C., preferably ⁇ 5 ° C. to 20 ° C., usually 1 minute to 24 hours, preferably 1 hour. By holding for ⁇ 15 hours.
- the precipitated compound (3) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation. If necessary, the compound (3) obtained by the solid-liquid separation operation may be washed with a solvent. Examples of the solvent used for washing include hydrocarbon solvents such as heptane, toluene and xylene; and alcohol solvents such as methanol, ethanol and isopropyl alcohol. Toluene, methanol and ethanol are preferably used.
- Compound (3) can be dried under normal pressure or reduced pressure.
- the purity of the obtained compound (3) is usually 99% or more. Purity can be confirmed by analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
- analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
- the obtained compound (3) may be further washed with a slurry by mixing and stirring with the poor solvent.
- step 2 ′ the mixture obtained in step 1 is reacted with 1,1′-carbonyldiimidazole.
- the reaction can be carried out in the same manner as in Step 2.
- the mixture obtained after completion of the reaction in Step 2 can be subjected to Step 3 ′ without purification. That is, the mixture obtained in step 2 ′ can be directly used in step 3 ′.
- step 3 The mixture obtained in step 2 ′ contains compound (3).
- Process 3 Step 3 will be described.
- compound (4) is obtained by reacting compound (3) with methylamine.
- the reaction is usually performed in a solvent.
- the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; alcohol solvents such as methanol, ethanol and isopropyl alcohol; tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether and the like.
- Ether solvents ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; nitrile solvents such as acetonitrile and propionitrile; and water.
- Methanol, ethanol, acetonitrile, and water are preferably used.
- Compound (3) may be a mixture obtained by the reaction in Step 2.
- the solvent used in Step 2 can be used as it is, but the solvent may be further mixed and used.
- Methylamine is usually mixed with a solvent and used as a liquid composition.
- a solvent examples include methanol, ethanol, isopropyl alcohol, and water, and methanol or water is preferably used.
- a commercially available liquid composition such as a methylamine aqueous solution may be used as it is.
- the amount of methylamine to be used is generally 1 mol to 10 mol, preferably 3 mol to 7 mol, per 1 mol of compound (3).
- the reaction is performed by mixing the compound (3) and methylamine.
- the mixing order is not particularly limited, and examples thereof include a method in which methylamine is added to a mixture of compound (3) and a solvent; compound (3) is added to a mixture of methylamine and a solvent. .
- the reaction temperature is usually within the range of 10 ° C to 80 ° C.
- the reaction time is usually in the range of 1 minute to 6 hours.
- step 4 After completion of the reaction, compound (4) can be subjected to step 4 without purification. That is, the mixture obtained in Step 3 can be directly used in Step 4.
- Compound (4) can also be isolated and purified by a conventional method. After completion of the reaction, for example, the reaction mixture is concentrated; the reaction mixture and water are mixed and separated, and then the obtained organic layer is washed, dried, concentrated, etc. Can be separated. Step 3 ' Step 3 ′ will be described. In step 3 ′, the mixture obtained in step 2 ′ is reacted with methylamine to obtain compound (4).
- Step 4 The reaction can be carried out in the same manner as in Step 3, using the mixture obtained in Step 2 ′ (including compound (3)).
- the amount of methylamine used in step 3 ′ is usually 1 to 10 mol, preferably 3 to 7 mol, per 1 mol of compound (1) used in step 1.
- Process 4 Step 4 will be described.
- compound (4) is reacted with hydrogen chloride to obtain hydrochloride of compound (4).
- the reaction is performed in a solvent or in the absence of a solvent.
- the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; alcohol solvents such as methanol, ethanol and isopropyl alcohol; tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether and the like.
- Ether solvents ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; nitrile solvents such as acetonitrile and propionitrile; and water.
- Methanol, ethanol, isopropyl alcohol, acetonitrile, and water are preferably used.
- Compound (4) may be a mixture obtained in Step 3 or Step 3 ′.
- the solvent used in Step 3 can be used as it is, but the solvent may be further mixed and used.
- hydrochloric acid aqueous solution of hydrogen chloride
- hydrogen chloride gas is usually used.
- hydrochloric acid When hydrochloric acid is used, its concentration is not limited, but 5 wt% to 35 wt% hydrochloric acid is preferably used.
- the reaction is carried out by mixing compound (4) and hydrogen chloride.
- the mixing order is not particularly limited. Specifically, hydrochloric acid is added to compound (4); hydrogen chloride gas is blown into a mixture of compound (4) and a solvent; compound (4) is added to hydrochloric acid, and compound (4) is mentioned. A method of adding hydrochloric acid to is preferable.
- the amount of hydrogen chloride to be used is usually 3 to 7 mol per 1 mol of compound (4) in which the reaction mixture has a pH of usually 0 to 5, preferably 1 to 4 is mixed.
- the reaction temperature is usually in the range of 10 ° C to 70 ° C.
- the reaction time is usually in the range of 1 minute to 5 hours.
- the reaction mixture is concentrated; by maintaining the reaction mixture at ⁇ 20 ° C. to 70 ° C., preferably ⁇ 5 ° C. to 60 ° C. for 1 minute to 20 hours, the hydrochloride of the compound (4) is obtained. Precipitate.
- the hydrochloride of the precipitated compound (4) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation.
- the hydrochloride of compound (4) obtained by the solid-liquid separation operation may be washed with a solvent, if necessary.
- the solvent used for washing include methanol, ethanol, isopropyl alcohol, acetonitrile, water, and an aqueous acetonitrile solution, and an acetonitrile or aqueous acetonitrile solution is preferable.
- step 5 The compound (4) can be dried under normal pressure or reduced pressure.
- Process 5 Step 5 will be described. In step 5, compound (4) hydrochloride and compound (5) are reacted in the presence of a base to obtain compound (6).
- the reaction is usually performed in a solvent.
- the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, 1,3-dimethyl- Amide solvents such as 2-imidazolidinone; heterocyclic aromatic solvents such as 1-methylimidazole; ether solvents such as tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether; acetone, methyl ethyl ketone, methyl isobutyl ketone, etc.
- examples thereof include ketone solvents; nitrile solvents such as acetonitrile and propionitrile; and water. Toluene, acetonitrile or water is preferably used.
- the reaction is carried out by mixing the hydrochloride of compound (4), compound (5) and a base.
- the order of mixing is not particularly limited, and for example, a base is added to a mixture of the hydrochloride salt of the compound (4), the compound (5) and the solvent; to the mixture of the hydrochloride salt of the compound (4), the base and the solvent.
- Compound (5) is usually mixed with a solvent and used as a liquid composition.
- a solvent include the same solvents as those used in the above reaction (excluding water).
- the amount of compound (5) to be used is generally 1 mol to 1.5 mol with respect to 1 mol of hydrochloride of compound (4).
- Examples of the base include lithium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, cesium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, triethylamine, diisopropylethylamine, diazabicycloundecene (DBU) and pyridine. And triethylamine is preferably used.
- the amount of the base used is generally 2 mol to 4 mol with respect to 1 mol of the hydrochloride of compound (4).
- the reaction temperature is usually in the range of 0 ° C to 60 ° C.
- the reaction time is usually in the range of 1 minute to 4 hours.
- the reaction mixture is concentrated; by maintaining the reaction mixture at ⁇ 20 ° C. to 50 ° C., preferably ⁇ 5 to 30 ° C. for 1 minute to 15 hours, the compound (6) is precipitated.
- the precipitated compound (6) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation. If necessary, the compound (6) obtained by the solid-liquid separation operation may be washed with a solvent. Examples of the solvent used for washing include methanol, ethanol, acetonitrile, and water, and acetonitrile or water is preferably used.
- Compound (6) can be dried under normal pressure or reduced pressure.
- the purity of the obtained compound (6) is usually 99% or more. Purity can be confirmed by analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
- analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
- the obtained compound (6) is dimethyl sulfoxide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, tetrahydrofuran, 1,4-dioxane. Further purity is achieved by recrystallization using a solvent such as acetone, methyl ethyl ketone, methyl isobutyl ketone, dichloromethane, chloroform, methanol, ethanol, butanol, 1-pentanol, acetonitrile, acetic acid, water, or a mixed solvent of the above solvents. Can also be increased. If necessary, the compound (6) obtained by recrystallization may be washed with a solvent. Examples of the solvent used for washing include methanol, ethanol, acetonitrile, and water, and methanol or water is preferably used.
- % related to concentration means weight% unless otherwise specified.
- HPLC high performance liquid chromatography
- UV measurement wavelength 250 nm Flow rate: 0.7 mL / min Column oven: 30 ° C [HPLC analysis condition 2] Measuring equipment: LC-10Avp manufactured by Shimadzu Corporation Mobile phase: Liquid A: 0.1% trifluoroacetic acid aqueous solution, liquid B: 0.1% trifluoroacetic acid-containing acetonitrile gradient conditions: Table 1 below Column: L-column 2 ODS, particle size 3 ⁇ m, 4.6 mm I.D. D. ⁇ 150mm (Chemicals Evaluation and Research Institute) UV measurement wavelength: 240 nm Flow rate: 1.0 mL / min Column oven: 35 ° C ⁇ Gradient condition>
- Example 8 5-chloro-N-( ⁇ (5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl ⁇ methyl) thiophene-2- Synthesis of carboxamide 4- ⁇ 4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl ⁇ morpholin-3-one hydrochloride 15.0 g (0.046 mol) ), 10.5 g of water and 75.0 g of acetonitrile were mixed at room temperature, and 11.6 g (0.114 mol) of triethylamine was added dropwise at 25 ° C.
- Example 12 2-( ⁇ (5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl ⁇ methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 2- (4-aminophenyl) morpholin-3-one 20.0 g (0.104 mol), (S) -N-glycidylphthalimide 21.1 g (0.104 mol), trifluoromethanesulfone A mixture of 1.0 g (2.5 mol%) of zinc acid (II) and 267.0 g of acetonitrile was stirred at 50 ° C. for 23 hours.
- Example 13 2-( ⁇ (5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl ⁇ methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 4- (4-aminophenyl) morpholin-3-one 40.0 g (0.208 mol), (S) -N-glycidylphthalimide 42.3 g (0.208 mol), trifluoromethanesulfone 3.8 g (5 mol%) of zinc (II) acid and 534.0 g of acetonitrile were mixed and stirred at 45 ° C. for 17 hours.
- Example 16 5-chloro-N-( ⁇ (5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl ⁇ methyl) thiophene-2- Synthesis of carboxamide 4- ⁇ 4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl ⁇ morpholin-3-one hydrochloride 15.0 g (0.046 mol) ), 10.5 g of water and 75.0 g of acetonitrile were mixed at room temperature, and 12.2 g (0.120 mol) of triethylamine was added dropwise at 25 ° C.
- the hydrochloride of compound (3) and compound (4) which are production intermediates of rivaroxaban useful as a pharmaceutical, and rivaroxaban can be efficiently produced.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、オキサゾリジノン化合物の製造方法に関する。 The present invention relates to a method for producing an oxazolidinone compound.
リバーロキサバン、即ち、式(6)
Rivaroxaban, ie, formula (6)
で表される化合物(以下、化合物(6)と記す)は、第Xa因子を直接阻害する経口抗凝固薬のひとつである。 (Hereinafter referred to as compound (6)) is one of oral anticoagulants that directly inhibits factor Xa.
AU2004313694Bには、化合物(6)の製造方法として、式(1)
AU2004313694B includes a compound represented by formula (1) as a method for producing compound (6).
で表される化合物(以下、化合物(1)と記す)と式(2)
(Hereinafter referred to as compound (1)) and formula (2)
で表される化合物(以下、化合物(2)と記す)とを反応させ、次いでホスゲン等価物を反応させることにより、製造中間体であるオキサゾリジノン化合物、即ち、式(3)
Is reacted with a compound represented by the following formula (hereinafter referred to as compound (2)), followed by reaction with a phosgene equivalent, that is, an oxazolidinone compound that is a production intermediate, that is, formula (3)
で表される化合物(以下、化合物(3)と記す)を製造し、化合物(3)から式(4)
(Hereinafter referred to as compound (3)), and from compound (3) to formula (4)
で表される化合物(以下、化合物(4)と記す)の塩酸塩を経由してリバーロキサバンを製造する方法が記載されている。また、製造中間体である化合物(3)の製造方法として、具体的には、第1工程として化合物(1)と化合物(2)とを、エタノールおよび水の混合溶媒中で反応させ、生じた式(7)
A method for producing rivaroxaban via the hydrochloride of a compound represented by the formula (hereinafter referred to as compound (4)) is described. Moreover, as a manufacturing method of compound (3) which is a manufacturing intermediate, specifically, compound (1) and compound (2) were reacted as a first step in a mixed solvent of ethanol and water. Formula (7)
で表される化合物(以下、化合物(7)と記す)を単離した後、第2工程としてN-メチルピロリドンまたはトルエン中で1,1’-カルボニルジイミダゾールを用いて化合物(7)を環化して化合物(3)を得る方法;化合物(3)とメチルアミンとをエタノール中で反応させて化合物(4)とし、塩酸を加えて化合物(4)の塩酸塩を得る方法;および化合物(4)の塩酸塩から化合物(6)を得る方法が開示されている。 And the compound (7) is then cyclized using 1,1′-carbonyldiimidazole in N-methylpyrrolidone or toluene as the second step. To obtain compound (3) by reacting compound (3) and methylamine in ethanol to obtain compound (4) and adding hydrochloric acid to obtain hydrochloride of compound (4); and compound (4) ) To obtain compound (6) from the hydrochloride salt thereof.
しかしながら、この方法では、化合物(3)の製造において、第2工程で水と反応して分解する性質を有する1,1’-カルボニルジイミダゾールを用いるにも関わらず、第1工程において溶媒としてエタノールおよび水の混合溶媒を使用するため、第1工程の反応終了後に水を除くために生じた化合物(7)を単離し十分に乾燥させる必要がある。また、第1工程で用いる化合物(2)は水の存在下で徐々に分解するため、分解物自体が不純物となり得るとともに、分解物が目的物または他の不純物と反応して新たな不純物を生じる可能性があるため、医薬品であるリバーロキサバンの製造において好ましくない。 However, in this method, in the production of compound (3), although 1,1′-carbonyldiimidazole having a property of decomposing by reacting with water in the second step is used, ethanol is used as a solvent in the first step. Since a mixed solvent of water and water is used, it is necessary to isolate and dry the compound (7) generated in order to remove water after the completion of the reaction in the first step. In addition, since the compound (2) used in the first step is gradually decomposed in the presence of water, the decomposed product itself can be an impurity, and the decomposed product reacts with the target product or other impurities to generate new impurities. This is not preferred in the production of rivaroxaban, a pharmaceutical product.
さらに、化合物(3)を得る第2工程と化合物(3)から化合物(4)を得る工程とで用いる溶媒が異なるため、前記第2工程においても化合物(3)を単離する必要がある。 Furthermore, since the solvent used in the second step for obtaining the compound (3) and the step for obtaining the compound (4) from the compound (3) are different, it is necessary to isolate the compound (3) also in the second step.
本発明は、医薬品として有用であるリバーロキサバンの製造中間体である化合物(3)の製造において溶媒として水を用いない効率的な製造方法、ならびに、それを用いた化合物(4)の塩酸塩およびリバーロキサバンの効率的な製造方法を提供する。 The present invention relates to an efficient production method in which water is not used as a solvent in the production of compound (3) which is a production intermediate of rivaroxaban useful as a pharmaceutical, and the hydrochloride of compound (4) using the same And an efficient method for producing rivaroxaban.
本発明は以下の通りである。
[1] 工程1および工程2を含む化合物(3)の製造方法:
工程1:アセトニトリル中、化合物(1)と化合物(2)とをトリフルオロメタンスルホナートの存在下で反応させる工程;
工程2:工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させ、化合物(3)を得る工程。
[2] [1]に記載の工程1および工程2に加えて工程3および工程4を含む化合物(4)の塩酸塩の製造方法:
工程3:化合物(3)とメチルアミンとを反応させて、化合物(4)を得る工程;
工程4:化合物(4)と塩化水素とを反応させて、化合物(4)の塩酸塩を得る工程。
[3] 工程1、工程2’、工程3’および工程4を含む化合物(4)の塩酸塩の製造方法:
工程1:アセトニトリル中、化合物(1)と化合物(2)とをトリフルオロメタンスルホナートの存在下で反応させる工程;
工程2’:工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させる工程;
工程3’:工程2’で得られた混合物とメチルアミンとを反応させて、化合物(4)を得る工程;
工程4:化合物(4)と塩化水素とを反応させて、化合物(4)の塩酸塩を得る工程。
[4] [2]または[3]に記載の化合物(4)の塩酸塩の製造方法、および工程5を含む化合物(6)の製造方法:
工程5:化合物(4)の塩酸塩と式(5)
The present invention is as follows.
[1] Method for producing compound (3) comprising step 1 and step 2:
Step 1: A step of reacting Compound (1) and Compound (2) in acetonitrile in the presence of trifluoromethanesulfonate;
Step 2: A step of reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole to obtain Compound (3).
[2] Method for producing hydrochloride of compound (4) comprising step 3 and step 4 in addition to step 1 and step 2 according to [1]:
Step 3: A step of obtaining a compound (4) by reacting a compound (3) with methylamine;
Step 4: A step of reacting compound (4) with hydrogen chloride to obtain hydrochloride of compound (4).
[3] Method for producing hydrochloride of compound (4) including step 1, step 2 ′, step 3 ′ and step 4:
Step 1: A step of reacting Compound (1) and Compound (2) in acetonitrile in the presence of trifluoromethanesulfonate;
Step 2 ′: reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole;
Step 3 ′: a step of reacting the mixture obtained in Step 2 ′ with methylamine to obtain compound (4);
Step 4: A step of reacting compound (4) with hydrogen chloride to obtain hydrochloride of compound (4).
[4] Method for producing hydrochloride of compound (4) according to [2] or [3], and method for producing compound (6) comprising step 5:
Step 5: Hydrochloride of compound (4) and formula (5)
で表される化合物(以下、化合物(5)と記す)とを塩基の存在下で反応させて、化合物(6)を得る工程。
[5] トリフルオロメタンスルホナートが、トリフルオロメタンスルホン酸亜鉛(II)、トリフルオロメタンスルホン酸イッテルビウム(III)またはトリフルオロメタンスルホン酸アルミニウム(III)である[1]~[4]のいずれかに記載の製造方法。
A compound represented by the formula (hereinafter referred to as compound (5)) in the presence of a base to obtain compound (6).
[5] The trifluoromethanesulfonate is any one of [1] to [4], which is zinc (II) trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate (III), or aluminum (III) trifluoromethanesulfonate. Production method.
以下、本発明について詳細に説明する。
工程1
工程1について説明する。工程1では、アセトニトリル中、化合物(1)と化合物(2)とをトリフルオロメタンスルホナートの存在下で反応させる。
Hereinafter, the present invention will be described in detail.
Process 1
Step 1 will be described. In step 1, compound (1) and compound (2) are reacted in acetonitrile in the presence of trifluoromethanesulfonate.
トリフルオロメタンスルホナートとしては、例えばトリフルオロメタンスルホン酸亜鉛(II)、トリフルオロメタンスルホン酸イッテルビウム(III)、トリフルオロメタンスルホン酸アルミニウム(III)、トリフルオロメタンスルホン酸リチウム、トリフルオロメタンスルホン酸カルシウム、トリフルオロメタンスルホン酸鉄(II)、トリフルオロメタンスルホン酸銅(II)およびトリフルオロメタンスルホン酸ビスマス(III)等のトリフルオロメタンスルホン酸金属塩、ならびにトリフルオロメタンスルホン酸トリエチルシリルが挙げられ、トリフルオロメタンスルホン酸亜鉛(II)、トリフルオロメタンスルホン酸イッテルビウム(III)およびトリフルオロメタンスルホン酸アルミニウム(III)が好ましく、トリフルオロメタンスルホン酸亜鉛(II)およびトリフルオロメタンスルホン酸イッテルビウム(III)がより好ましい。トリフルオロメタンスルホナートは、無水物であっても水和物であってもよく、市販のものをそのまま用いることができる。 Examples of the trifluoromethanesulfonate include zinc (II) trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate (III), aluminum trifluoromethanesulfonate (III), lithium trifluoromethanesulfonate, calcium trifluoromethanesulfonate, and trifluoromethanesulfone. Trifluoromethanesulfonic acid metal salts such as iron (II) acid, copper (II) trifluoromethanesulfonate and bismuth (III) trifluoromethanesulfonate, and triethylsilyl trifluoromethanesulfonate, and zinc trifluoromethanesulfonate (II ), Ytterbium trifluoromethanesulfonate (III) and aluminum (III) trifluoromethanesulfonate are preferred. , Zinc trifluoromethanesulfonate (II) and trifluoromethanesulfonic acid ytterbium (III) are more preferable. Trifluoromethanesulfonate may be an anhydride or a hydrate, and a commercially available product can be used as it is.
トリフルオロメタンスルホナートの使用量は、化合物(1)1モルに対して、通常0.01モル~0.20モル、好ましくは0.02モル~0.07モルである。 The amount of trifluoromethanesulfonate to be used is generally 0.01 mol to 0.20 mol, preferably 0.02 mol to 0.07 mol, per 1 mol of compound (1).
化合物(2)の使用量は、化合物(1)1モルに対して、通常1モル~1.5モル、好ましくは1.00モル~1.05モルである。 The amount of compound (2) to be used is generally 1 mol to 1.5 mol, preferably 1.00 mol to 1.05 mol, per 1 mol of compound (1).
工程1で用いるアセトニトリルは、含水量が少ないものがより好ましい。アセトニトリルの含水量が多い場合、水によって化合物(2)が分解される虞があり、また、工程2において用いる1,1’-カルボニルジイミダゾールが加水分解されるため、好ましくない。そのため、工程1で用いるアセトニトリルの含水量は、通常0%~0.05%であり、好ましくは0%~0.02%であり、より好ましくは0%~0.01%である。アセトニトリルの含水量は、カールフィッシャー法により測定することができる。 The acetonitrile used in step 1 is more preferably one having a low water content. When the water content of acetonitrile is large, the compound (2) may be decomposed by water, and 1,1′-carbonyldiimidazole used in Step 2 is hydrolyzed, which is not preferable. Therefore, the water content of acetonitrile used in Step 1 is usually 0% to 0.05%, preferably 0% to 0.02%, more preferably 0% to 0.01%. The water content of acetonitrile can be measured by the Karl Fischer method.
アセトニトリルの使用量は、化合物(1)1重量部に対して3重量部以上であればよく、通常5重量部~20重量部、好ましくは7重量部~15重量部である。 The amount of acetonitrile used may be 3 parts by weight or more with respect to 1 part by weight of the compound (1), and is usually 5 parts by weight to 20 parts by weight, preferably 7 parts by weight to 15 parts by weight.
反応は、化合物(1)、化合物(2)、トリフルオロメタンスルホナートおよびアセトニトリルを混合することにより行われる。化合物(1)、化合物(2)、トリフルオロメタンスルホナートおよびアセトニトリルの混合において、混合順序に特に限定はなく、例えば、アセトニトリル、化合物(1)および化合物(2)を混合した後、トリフルオロメタンスルホナートを添加する;化合物(1)、化合物(2)およびトリフルオロメタンスルホナートを混合した後にアセトニトリルを添加する、方法により実施できる。 The reaction is carried out by mixing compound (1), compound (2), trifluoromethanesulfonate and acetonitrile. The mixing order of compound (1), compound (2), trifluoromethanesulfonate and acetonitrile is not particularly limited. For example, after mixing acetonitrile, compound (1) and compound (2), trifluoromethanesulfonate is mixed. The compound (1), the compound (2) and trifluoromethanesulfonate are mixed and then acetonitrile is added.
反応温度は通常1℃~80℃の範囲内、好ましくは5℃~55℃の範囲内である。 The reaction temperature is usually in the range of 1 ° C to 80 ° C, preferably in the range of 5 ° C to 55 ° C.
反応時間は通常1時間~60時間である。 The reaction time is usually 1 to 60 hours.
この反応により、化合物(7)を含む混合物が得られる。 By this reaction, a mixture containing the compound (7) is obtained.
工程1で得られた混合物は、工程2にそのまま供することができる。
工程2
工程2について説明する。工程2では、工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させ、化合物(3)を得る。
The mixture obtained in step 1 can be directly used in step 2.
Process 2
Step 2 will be described. In step 2, the mixture obtained in step 1 is reacted with 1,1′-carbonyldiimidazole to obtain compound (3).
1,1’-カルボニルジイミダゾールの使用量は、工程1で用いた化合物(1)1モルに対して、通常1モル~3モル、好ましくは1.0モル~1.5モルである。 The amount of 1,1'-carbonyldiimidazole to be used is generally 1 mol-3 mol, preferably 1.0 mol-1.5 mol, per 1 mol of compound (1) used in Step 1.
反応は、工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを混合することにより行われる。操作性の観点から、工程1で得られた混合物に1,1’-カルボニルジイミダゾールを添加するのが好ましい。工程1で得られた混合物に1,1’-カルボニルジイミダゾールを添加するには、1,1’-カルボニルジイミダゾールの全量を一度に添加してもよいし、1,1’-カルボニルジイミダゾールを分割して、複数回に分けて添加してもよい。 The reaction is carried out by mixing the mixture obtained in step 1 and 1,1'-carbonyldiimidazole. From the viewpoint of operability, 1,1′-carbonyldiimidazole is preferably added to the mixture obtained in Step 1. In order to add 1,1′-carbonyldiimidazole to the mixture obtained in Step 1, the entire amount of 1,1′-carbonyldiimidazole may be added all at once, or 1,1′-carbonyldiimidazole may be added. May be divided and added in multiple portions.
添加は、通常1℃~80℃の範囲内、好ましくは5℃~55℃の範囲内で行われる。 The addition is usually performed within a range of 1 ° C to 80 ° C, preferably within a range of 5 ° C to 55 ° C.
反応温度は、通常1℃~80℃の範囲内、好ましくは40℃~80℃の範囲内である。 The reaction temperature is usually in the range of 1 ° C to 80 ° C, preferably in the range of 40 ° C to 80 ° C.
反応時間は、通常1分~10時間である。 The reaction time is usually 1 minute to 10 hours.
工程2の反応終了後は、例えば、反応混合物と貧溶媒とを混合することにより、化合物(3)を析出させて単離することができる。 After completion of the reaction in Step 2, for example, the compound (3) can be precipitated and isolated by mixing the reaction mixture and a poor solvent.
貧溶媒としては、例えばヘプタン、トルエン、キシレン等の炭化水素溶媒;モノクロロベンゼン等のハロゲン化炭化水素溶媒;ジイソプロピルエーテル、メチルtert-ブチルエーテル等のエーテル溶媒;メタノール、エタノール、イソプロピルアルコール等のアルコール溶媒;および水が挙げられ、トルエン、メタノールまたはエタノールが好ましく用いられる。 Examples of the poor solvent include hydrocarbon solvents such as heptane, toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; ether solvents such as diisopropyl ether and methyl tert-butyl ether; alcohol solvents such as methanol, ethanol and isopropyl alcohol; And toluene, and toluene, methanol or ethanol is preferably used.
貧溶媒の使用量は、工程1で用いた化合物(1)1重量部に対して、通常2重量部~20重量部、好ましくは5重量部~15重量部である。 The amount of the poor solvent used is usually 2 to 20 parts by weight, preferably 5 to 15 parts by weight, based on 1 part by weight of the compound (1) used in Step 1.
前記混合は、通常1℃~60℃の範囲内、好ましくは20℃~60℃の範囲内で行われる。操作性の観点から、反応混合物に対して貧溶媒を添加することにより実施することが好ましい。 The mixing is usually performed within a range of 1 ° C to 60 ° C, preferably within a range of 20 ° C to 60 ° C. From the viewpoint of operability, it is preferable to carry out by adding a poor solvent to the reaction mixture.
前記混合により、通常、化合物(3)が結晶として析出する。化合物(3)の析出を促進させるために、必要により、化合物(3)の種結晶を添加してもよい。 The compound (3) is usually precipitated as crystals by the mixing. In order to promote the precipitation of the compound (3), a seed crystal of the compound (3) may be added as necessary.
種結晶を添加する場合、その添加量は、工程1で用いた化合物(1)1重量部に対して、0.00l重量部~0.01重量部であり、添加は通常1℃~70℃の範囲内、好ましくは20℃~60℃の範囲内で行われる。 When seed crystals are added, the amount added is 0.001 parts by weight to 0.01 parts by weight with respect to 1 part by weight of the compound (1) used in Step 1, and the addition is usually 1 ° C. to 70 ° C. Is preferably within the range of 20 ° C to 60 ° C.
結晶の析出は、反応混合物と貧溶媒、さらに必要により種結晶を混合した後、通常-20℃~60℃、好ましくは-5℃~20℃で、通常1分~24時間、好ましくは1時間~15時間保持することにより行われる。 Crystals are precipitated by mixing the reaction mixture with a poor solvent and, if necessary, seed crystals, usually at −20 ° C. to 60 ° C., preferably −5 ° C. to 20 ° C., usually 1 minute to 24 hours, preferably 1 hour. By holding for ~ 15 hours.
析出した化合物(3)は、固液分離の手法に従って取得することができる。具体的には、濾過、デカンテーション等の固液分離操作が挙げられる。固液分離操作により得られた化合物(3)は、必要により、溶媒による洗浄を行ってもよい。洗浄に用いる溶媒としては、例えば、ヘプタン、トルエン、キシレン等の炭化水素溶媒;およびメタノール、エタノール、イソプロピルアルコール等のアルコール溶媒が挙げられ、トルエン、メタノールまたはエタノールが好ましく用いられる。 The precipitated compound (3) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation. If necessary, the compound (3) obtained by the solid-liquid separation operation may be washed with a solvent. Examples of the solvent used for washing include hydrocarbon solvents such as heptane, toluene and xylene; and alcohol solvents such as methanol, ethanol and isopropyl alcohol. Toluene, methanol and ethanol are preferably used.
化合物(3)の乾燥は、常圧または減圧下で行うことができる。 Compound (3) can be dried under normal pressure or reduced pressure.
得られた化合物(3)の純度は、通常99%以上である。純度は、ガスクロマトグラフィー(GC)、高速液体クロマトグラフィー(HPLC)等の分析手段により確認することができる。 The purity of the obtained compound (3) is usually 99% or more. Purity can be confirmed by analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
得られた化合物(3)は、前記貧溶媒と混合撹拌することにより、スラリー洗浄をさらに行ってもよい。 The obtained compound (3) may be further washed with a slurry by mixing and stirring with the poor solvent.
また、工程2の反応終了後、化合物(3)は精製することなしに工程3に供することもできる。即ち、工程2で得られた混合物は、工程3にそのまま供することができる。
工程2’
工程2’について説明する。工程2’では、工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させる。反応は工程2と同様に実施することができる。工程2の反応終了後に得られた混合物は、精製することなしに工程3’に供することができる。即ち、工程2’で得られた混合物は、工程3’にそのまま供することができる。
Moreover, after completion | finish of reaction of the process 2, a compound (3) can also be used for the process 3 without refine | purifying. That is, the mixture obtained in step 2 can be directly used in step 3.
Process 2 '
Step 2 ′ will be described. In step 2 ′, the mixture obtained in step 1 is reacted with 1,1′-carbonyldiimidazole. The reaction can be carried out in the same manner as in Step 2. The mixture obtained after completion of the reaction in Step 2 can be subjected to Step 3 ′ without purification. That is, the mixture obtained in step 2 ′ can be directly used in step 3 ′.
工程2’で得られた混合物は、化合物(3)を含む。
工程3
工程3について説明する。工程3では、化合物(3)とメチルアミンとを反応させて、化合物(4)を得る。
The mixture obtained in step 2 ′ contains compound (3).
Process 3
Step 3 will be described. In step 3, compound (4) is obtained by reacting compound (3) with methylamine.
反応は、通常溶媒中で行われる。溶媒としては、例えば、トルエン、キシレン等の炭化水素溶媒;モノクロロベンゼン等のハロゲン化炭化水素溶媒;メタノール、エタノール、イソプロピルアルコール等のアルコール溶媒;テトラヒドロフラン、ジイソプロピルエーテル、メチルtert-ブチルエーテル、シクロペンチルメチルエーテル等のエーテル溶媒;アセトン、メチルエチルケトン、メチルイソブチルケトン等のケトン溶媒;アセトニトリル、プロピオニトリル等のニトリル溶媒;および水が挙げられ、メタノール、エタノール、アセトニトリルまたは水が好ましく用いられる。 The reaction is usually performed in a solvent. Examples of the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; alcohol solvents such as methanol, ethanol and isopropyl alcohol; tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether and the like. Ether solvents; ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; nitrile solvents such as acetonitrile and propionitrile; and water. Methanol, ethanol, acetonitrile, and water are preferably used.
化合物(3)は、工程2の反応で得られた混合物であってもよい。工程2で得られた混合物を工程3にそのまま供する場合、工程2で用いた溶媒をそのまま用いることもできるが、さらに前記溶媒を混合して使用してもよい。 Compound (3) may be a mixture obtained by the reaction in Step 2. When the mixture obtained in Step 2 is directly used in Step 3, the solvent used in Step 2 can be used as it is, but the solvent may be further mixed and used.
メチルアミンは通常、溶媒と混合して液状組成物として用いる。かかる溶媒としては、例えば、メタノール、エタノール、イソプロピルアルコールおよび水が挙げられ、メタノールまたは水が好ましく用いられる。メチルアミン水溶液等の市販の液状組成物をそのまま用いてもよい。 Methylamine is usually mixed with a solvent and used as a liquid composition. Examples of such a solvent include methanol, ethanol, isopropyl alcohol, and water, and methanol or water is preferably used. A commercially available liquid composition such as a methylamine aqueous solution may be used as it is.
メチルアミンの使用量は、化合物(3)1モルに対して、通常1モル~10モル、好ましくは3モル~7モルである。 The amount of methylamine to be used is generally 1 mol to 10 mol, preferably 3 mol to 7 mol, per 1 mol of compound (3).
反応は、化合物(3)とメチルアミンとを混合することにより行われる。前記混合において、混合順序に特に限定はなく、例えば、化合物(3)と溶媒との混合物にメチルアミンを添加する;メチルアミンと溶媒との混合物に化合物(3)を添加する、方法が挙げられる。 The reaction is performed by mixing the compound (3) and methylamine. In the mixing, the mixing order is not particularly limited, and examples thereof include a method in which methylamine is added to a mixture of compound (3) and a solvent; compound (3) is added to a mixture of methylamine and a solvent. .
反応温度は、通常10℃~80℃の範囲内である。 The reaction temperature is usually within the range of 10 ° C to 80 ° C.
反応時間は、通常1分~6時間の範囲内である。 The reaction time is usually in the range of 1 minute to 6 hours.
反応終了後、化合物(4)は精製することなしに工程4に供することができる。即ち、工程3で得られた混合物は、工程4にそのまま供することができる。 After completion of the reaction, compound (4) can be subjected to step 4 without purification. That is, the mixture obtained in Step 3 can be directly used in Step 4.
化合物(4)は、常法によって単離、精製することもできる。反応終了後、例えば、反応混合物を濃縮する;反応混合物と水とを混合し、分液を行った後、得られた有機層を洗浄、乾燥、濃縮等することにより、化合物(4)を単離することができる。
工程3’
工程3’について説明する。工程3’では、工程2’で得られた混合物とメチルアミンとを反応させて、化合物(4)を得る。
Compound (4) can also be isolated and purified by a conventional method. After completion of the reaction, for example, the reaction mixture is concentrated; the reaction mixture and water are mixed and separated, and then the obtained organic layer is washed, dried, concentrated, etc. Can be separated.
Step 3 '
Step 3 ′ will be described. In step 3 ′, the mixture obtained in step 2 ′ is reacted with methylamine to obtain compound (4).
反応は、(化合物(3)を含む)工程2’で得られた混合物を用い、工程3と同様に実施することができる。但し、工程3’におけるメチルアミンの使用量は、工程1で用いた化合物(1)1モルに対して、通常1モル~10モル、好ましくは3モル~7モルである。
工程4
工程4について説明する。工程4では、化合物(4)と塩化水素とを反応させて、化合物(4)の塩酸塩を得る。
The reaction can be carried out in the same manner as in Step 3, using the mixture obtained in Step 2 ′ (including compound (3)). However, the amount of methylamine used in step 3 ′ is usually 1 to 10 mol, preferably 3 to 7 mol, per 1 mol of compound (1) used in step 1.
Process 4
Step 4 will be described. In step 4, compound (4) is reacted with hydrogen chloride to obtain hydrochloride of compound (4).
反応は、溶媒中または溶媒の非存在下で行われる。溶媒としては、例えば、トルエン、キシレン等の炭化水素溶媒;モノクロロベンゼン等のハロゲン化炭化水素溶媒;メタノール、エタノール、イソプロピルアルコール等のアルコール溶媒;テトラヒドロフラン、ジイソプロピルエーテル、メチルtert-ブチルエーテル、シクロペンチルメチルエーテル等のエーテル溶媒;アセトン、メチルエチルケトン、メチルイソブチルケトン等のケトン溶媒;アセトニトリル、プロピオニトリル等のニトリル溶媒;および水が挙げられ、メタノール、エタノール、イソプロピルアルコール、アセトニトリルまたは水が好ましく用いられる。 The reaction is performed in a solvent or in the absence of a solvent. Examples of the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; alcohol solvents such as methanol, ethanol and isopropyl alcohol; tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether and the like. Ether solvents; ketone solvents such as acetone, methyl ethyl ketone, and methyl isobutyl ketone; nitrile solvents such as acetonitrile and propionitrile; and water. Methanol, ethanol, isopropyl alcohol, acetonitrile, and water are preferably used.
化合物(4)は、工程3または工程3’で得られた混合物であってもよい。工程3または工程3’で得られた混合物を工程4にそのまま供する場合、工程3で用いた溶媒をそのまま用いることもできるが、さらに前記溶媒を混合して使用してもよい。 Compound (4) may be a mixture obtained in Step 3 or Step 3 ′. When the mixture obtained in Step 3 or Step 3 'is directly used in Step 4, the solvent used in Step 3 can be used as it is, but the solvent may be further mixed and used.
塩化水素としては、通常、塩酸(塩化水素の水溶液)または塩化水素ガスが用いられる。 As hydrogen chloride, hydrochloric acid (aqueous solution of hydrogen chloride) or hydrogen chloride gas is usually used.
塩酸を用いる場合、その濃度に限定はないが、5重量%~35重量%塩酸が好ましく用いられる。 When hydrochloric acid is used, its concentration is not limited, but 5 wt% to 35 wt% hydrochloric acid is preferably used.
反応は、化合物(4)と塩化水素とを混合することにより行われる。前記混合において、混合順序に特に限定はない。具体的には、化合物(4)に塩酸を添加する;化合物(4)と溶媒との混合物に塩化水素ガスを吹き込む;塩酸に化合物(4)を添加する、方法が挙げられ、化合物(4)に塩酸を添加する方法が好ましい。 The reaction is carried out by mixing compound (4) and hydrogen chloride. In the mixing, the mixing order is not particularly limited. Specifically, hydrochloric acid is added to compound (4); hydrogen chloride gas is blown into a mixture of compound (4) and a solvent; compound (4) is added to hydrochloric acid, and compound (4) is mentioned. A method of adding hydrochloric acid to is preferable.
塩化水素の使用量は、反応混合物のpHが通常0~5に、好ましくは1~4になる量が混合され、化合物(4)1モルに対して、通常3モル~7モルである。 The amount of hydrogen chloride to be used is usually 3 to 7 mol per 1 mol of compound (4) in which the reaction mixture has a pH of usually 0 to 5, preferably 1 to 4 is mixed.
反応温度は、通常10℃~70℃の範囲内である。 The reaction temperature is usually in the range of 10 ° C to 70 ° C.
反応時間は、通常1分~5時間の範囲内である。 The reaction time is usually in the range of 1 minute to 5 hours.
反応終了後、例えば、反応混合物を濃縮する;反応混合物を-20℃~70℃、好ましくは-5℃~60℃で、1分~20時間保持することにより、化合物(4)の塩酸塩が析出する。 After completion of the reaction, for example, the reaction mixture is concentrated; by maintaining the reaction mixture at −20 ° C. to 70 ° C., preferably −5 ° C. to 60 ° C. for 1 minute to 20 hours, the hydrochloride of the compound (4) is obtained. Precipitate.
析出した化合物(4)の塩酸塩は、固液分離の手法に従って取得することができる。具体的には、濾過、デカンテーション等の固液分離操作が挙げられる。固液分離操作により得られた化合物(4)の塩酸塩は、必要により、溶媒による洗浄を行ってもよい。洗浄に用いる溶媒としては、例えば、メタノール、エタノール、イソプロピルアルコール、アセトニトリル、水およびアセトニトリル水溶液が挙げられ、アセトニトリルまたはアセトニトリル水溶液が好ましい。 The hydrochloride of the precipitated compound (4) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation. The hydrochloride of compound (4) obtained by the solid-liquid separation operation may be washed with a solvent, if necessary. Examples of the solvent used for washing include methanol, ethanol, isopropyl alcohol, acetonitrile, water, and an aqueous acetonitrile solution, and an acetonitrile or aqueous acetonitrile solution is preferable.
化合物(4)の乾燥は、常圧または減圧下で行うことができる。
工程5
工程5について説明する。工程5では、化合物(4)の塩酸塩と化合物(5)とを塩基の存在下で反応させて、化合物(6)を得る。
The compound (4) can be dried under normal pressure or reduced pressure.
Process 5
Step 5 will be described. In step 5, compound (4) hydrochloride and compound (5) are reacted in the presence of a base to obtain compound (6).
反応は、通常溶媒中で行われる。溶媒としては、例えば、トルエン、キシレン等の炭化水素溶媒;モノクロロベンゼン等のハロゲン化炭化水素溶媒;N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン等のアミド溶媒;1-メチルイミダゾール等の複素環式芳香族溶媒;テトラヒドロフラン、ジイソプロピルエーテル、メチルtert-ブチルエーテル、シクロペンチルメチルエーテル等のエーテル溶媒;アセトン、メチルエチルケトン、メチルイソブチルケトン等のケトン溶媒;アセトニトリル、プロピオニトリル等のニトリル溶媒;および水が挙げられ、トルエン、アセトニトリルまたは水が好ましく用いられる。 The reaction is usually performed in a solvent. Examples of the solvent include hydrocarbon solvents such as toluene and xylene; halogenated hydrocarbon solvents such as monochlorobenzene; N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, 1,3-dimethyl- Amide solvents such as 2-imidazolidinone; heterocyclic aromatic solvents such as 1-methylimidazole; ether solvents such as tetrahydrofuran, diisopropyl ether, methyl tert-butyl ether, cyclopentyl methyl ether; acetone, methyl ethyl ketone, methyl isobutyl ketone, etc. Examples thereof include ketone solvents; nitrile solvents such as acetonitrile and propionitrile; and water. Toluene, acetonitrile or water is preferably used.
反応は、化合物(4)の塩酸塩、化合物(5)および塩基を混合することにより行われる。前記混合において、混合順序に特に限定はなく、例えば、化合物(4)の塩酸塩、化合物(5)および溶媒の混合物に塩基を添加する;化合物(4)の塩酸塩、塩基および溶媒の混合物に化合物(5)を添加する、方法が挙げられる。 The reaction is carried out by mixing the hydrochloride of compound (4), compound (5) and a base. In the mixing, the order of mixing is not particularly limited, and for example, a base is added to a mixture of the hydrochloride salt of the compound (4), the compound (5) and the solvent; to the mixture of the hydrochloride salt of the compound (4), the base and the solvent The method of adding a compound (5) is mentioned.
化合物(5)は通常、溶媒と混合して液状組成物として用いられる。かかる溶媒としては、前記の反応に用いられる溶媒と同じもの(但し、水を除く。)が挙げられる。 Compound (5) is usually mixed with a solvent and used as a liquid composition. Examples of such a solvent include the same solvents as those used in the above reaction (excluding water).
化合物(5)の使用量は、化合物(4)の塩酸塩1モルに対して、通常1モル~1.5モルである。 The amount of compound (5) to be used is generally 1 mol to 1.5 mol with respect to 1 mol of hydrochloride of compound (4).
塩基としては、例えば、炭酸リチウム、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリウム、炭酸セシウム、水酸化リチウム、水酸化ナトリウム、水酸化カリウム、トリエチルアミン、ジイソプロピルエチルアミン、ジアザビシクロウンデセン(DBU)およびピリジンが挙げられ、トリエチルアミンが好ましく用いられる。 Examples of the base include lithium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, cesium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, triethylamine, diisopropylethylamine, diazabicycloundecene (DBU) and pyridine. And triethylamine is preferably used.
塩基の使用量は、化合物(4)の塩酸塩1モルに対して、通常2モル~4モルである。 The amount of the base used is generally 2 mol to 4 mol with respect to 1 mol of the hydrochloride of compound (4).
反応温度は、通常0℃~60℃の範囲内である。 The reaction temperature is usually in the range of 0 ° C to 60 ° C.
反応時間は、通常1分~4時間の範囲内である。 The reaction time is usually in the range of 1 minute to 4 hours.
反応終了後、例えば、反応混合物を濃縮する;反応混合物を-20℃~50℃、好ましくは-5~30℃で、1分~15時間保持することにより、化合物(6)が析出する。 After completion of the reaction, for example, the reaction mixture is concentrated; by maintaining the reaction mixture at −20 ° C. to 50 ° C., preferably −5 to 30 ° C. for 1 minute to 15 hours, the compound (6) is precipitated.
析出した化合物(6)は、固液分離の手法に従って取得することができる。具体的には、濾過、デカンテーション等の固液分離操作が挙げられる。固液分離操作により得られた化合物(6)は、必要により、溶媒による洗浄を行ってもよい。洗浄に用いる溶媒としては、例えば、メタノール、エタノール、アセトニトリルおよび水が挙げられ、アセトニトリルまたは水が好ましく用いられる。 The precipitated compound (6) can be obtained according to a solid-liquid separation technique. Specific examples include solid-liquid separation operations such as filtration and decantation. If necessary, the compound (6) obtained by the solid-liquid separation operation may be washed with a solvent. Examples of the solvent used for washing include methanol, ethanol, acetonitrile, and water, and acetonitrile or water is preferably used.
化合物(6)の乾燥は、常圧または減圧下で行うことができる。 Compound (6) can be dried under normal pressure or reduced pressure.
得られた化合物(6)の純度は、通常99%以上である。純度は、ガスクロマトグラフィー(GC)、高速液体クロマトグラフィー(HPLC)等の分析手段により確認することができる。 The purity of the obtained compound (6) is usually 99% or more. Purity can be confirmed by analytical means such as gas chromatography (GC) and high performance liquid chromatography (HPLC).
得られた化合物(6)は、ジメチルスルホキシド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、テトラヒドロフラン、1,4-ジオキサン、アセトン、メチルエチルケトン、メチルイソブチルケトン、ジクロロメタン、クロロホルム、メタノール、エタノール、ブタノール、1-ペンタノール、アセトニトリル、酢酸、水等の溶媒または前記溶媒の混合溶媒を用いて再結晶を行うことにより、さらに純度を高めることもできる。再結晶により得られた化合物(6)は、必要により、溶媒による洗浄を行ってもよい。洗浄に用いる溶媒としては、例えば、メタノール、エタノール、アセトニトリルおよび水が挙げられ、メタノールまたは水が好ましく用いられる。 The obtained compound (6) is dimethyl sulfoxide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, tetrahydrofuran, 1,4-dioxane. Further purity is achieved by recrystallization using a solvent such as acetone, methyl ethyl ketone, methyl isobutyl ketone, dichloromethane, chloroform, methanol, ethanol, butanol, 1-pentanol, acetonitrile, acetic acid, water, or a mixed solvent of the above solvents. Can also be increased. If necessary, the compound (6) obtained by recrystallization may be washed with a solvent. Examples of the solvent used for washing include methanol, ethanol, acetonitrile, and water, and methanol or water is preferably used.
以下、実施例により本発明をさらに詳しく説明するが、本発明はこれらの例に限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
以下の例において、濃度に係る「%」は、特に記載がない場合、重量%を意味する。 In the following examples, “%” related to concentration means weight% unless otherwise specified.
以下の例において、特に記載のない場合、化合物の純度は高速液体クロマトグラフィー(以下、HPLCと記す。)を用いて分析を行い、面積百分率法で求めた。その分析条件は以下の通りである。
[HPLC分析条件1]
測定機器:島津製作所製 LC-10Avp
移動相:A液:アセトニトリル、B液:アセトニトリル
カラム:CHIRALPAK(登録商標)IC、粒径 5μm、4.6mmI.D.×250mm(株式会社ダイセル製)
UV測定波長:250nm
流量:0.7mL/min
カラムオーブン:30℃
[HPLC分析条件2]
測定機器:島津製作所製 LC-10Avp
移動相:A液:0.1%トリフルオロ酢酸水溶液、B液:0.1%トリフルオロ酢酸含有アセトニトリル
グラジエント条件:下表1
カラム:L-column2 ODS、粒径 3μm、4.6mmI.D.×150mm(一般財団法人化学物質評価研究機構製)
UV測定波長:240nm
流量:1.0mL/min
カラムオーブン:35℃
<グラジエント条件>
In the following examples, unless otherwise specified, the purity of a compound was analyzed by high performance liquid chromatography (hereinafter referred to as HPLC) and determined by an area percentage method. The analysis conditions are as follows.
[HPLC analysis condition 1]
Measuring equipment: LC-10Avp manufactured by Shimadzu Corporation
Mobile phase: A liquid: acetonitrile, B liquid: acetonitrile column: CHIRALPAK (registered trademark) IC, particle size 5 μm, 4.6 mm D. × 250mm (manufactured by Daicel Corporation)
UV measurement wavelength: 250 nm
Flow rate: 0.7 mL / min
Column oven: 30 ° C
[HPLC analysis condition 2]
Measuring equipment: LC-10Avp manufactured by Shimadzu Corporation
Mobile phase: Liquid A: 0.1% trifluoroacetic acid aqueous solution, liquid B: 0.1% trifluoroacetic acid-containing acetonitrile gradient conditions: Table 1 below
Column: L-column 2 ODS, particle size 3 μm, 4.6 mm I.D. D. × 150mm (Chemicals Evaluation and Research Institute)
UV measurement wavelength: 240 nm
Flow rate: 1.0 mL / min
Column oven: 35 ° C
<Gradient condition>
表1
Table 1
実施例1
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド15.9g(0.078mol)、トリフルオロメタンスルホン酸イッテルビウム(III)水和物1.2g(2.5mol%)およびアセトニトリル105.0gを混合し、40℃で20時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール17.1g(0.105mol)を加え、75℃で7.5時間撹拌した。50℃でメタノール105.0gを滴加し、0.5時間撹拌した後、0℃に冷却して、6時間撹拌した後、析出した結晶を濾過により単離した。得られた結晶をメタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン28.8g(収率88%)を得た(HPLC純度(HPLC分析条件2):99.6%)。
Example 1
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 15.0 g (0.078 mol) 4- (4-aminophenyl) morpholin-3-one, 15.9 g (0.078 mol) (S) -N-glycidylphthalimide, trifluoromethanesulfone 1.2 g (2.5 mol%) of ytterbium (III) acid hydrate and 105.0 g of acetonitrile were mixed and stirred at 40 ° C. for 20 hours. To the resulting mixture, 17.1 g (0.105 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 7.5 hours. 105.0 g of methanol was added dropwise at 50 ° C. and stirred for 0.5 hour, then cooled to 0 ° C. and stirred for 6 hours, and then the precipitated crystals were isolated by filtration. The obtained crystals were washed with methanol and then dried under reduced pressure at a bath temperature of 50 ° C. to give 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (88% yield) (HPLC purity (HPLC analysis condition 2)): 99 .6%).
実施例2
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド15.9g(0.078mol)、トリフルオロメタンスルホン酸イッテルビウム(III)水和物1.2g(2.5mol%)およびアセトニトリル105.0gを混合し、30℃で25時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール15.8g(0.098mol)を加え、75℃で4.5時間撹拌した。50℃でメタノール105.0gを滴加し、0.5時間撹拌した後、-10℃に冷却して、1.5時間撹拌した後、析出した結晶を濾過により単離した。得られた結晶をメタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン29.3g(収率89%)を得た(HPLC純度(HPLC分析条件2):99.7%)。
Example 2
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 15.0 g (0.078 mol) 4- (4-aminophenyl) morpholin-3-one, 15.9 g (0.078 mol) (S) -N-glycidylphthalimide, trifluoromethanesulfone 1.2 g (2.5 mol%) of ytterbium acid (III) hydrate and 105.0 g of acetonitrile were mixed and stirred at 30 ° C. for 25 hours. To the obtained mixture, 15.8 g (0.098 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 4.5 hours. 105.0 g of methanol was added dropwise at 50 ° C. and stirred for 0.5 hour, then cooled to −10 ° C. and stirred for 1.5 hours, and then the precipitated crystals were isolated by filtration. The obtained crystals were washed with methanol and then dried under reduced pressure at a bath temperature of 50 ° C. to give 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (29.3 g, yield 89%) was obtained (HPLC purity (HPLC analysis condition 2)): 99 .7%).
実施例3
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド15.9g(0.078mol)、トリフルオロメタンスルホン酸イッテルビウム(III)水和物2.4g(5mol%)およびアセトニトリル105.0gを混合し、10℃で54時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール17.1g(0.105mol)を加え、75℃で2時間撹拌した。50℃で水105.0gを滴加し、0.5時間撹拌した後、0℃に冷却して、7時間撹拌した後、析出した結晶を濾過により単離した。得られた結晶を水で洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン27.9g(収率85%)を得た(HPLC純度(HPLC分析条件2):99.7%)。
Example 3
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 15.0 g (0.078 mol) 4- (4-aminophenyl) morpholin-3-one, 15.9 g (0.078 mol) (S) -N-glycidylphthalimide, trifluoromethanesulfone 2.4 g (5 mol%) of ytterbium (III) acid hydrate and 105.0 g of acetonitrile were mixed and stirred at 10 ° C. for 54 hours. To the resulting mixture, 17.1 g (0.105 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2 hours. 105.0 g of water was added dropwise at 50 ° C. and stirred for 0.5 hour, then cooled to 0 ° C. and stirred for 7 hours, and then the precipitated crystals were isolated by filtration. The obtained crystals were washed with water and dried under reduced pressure at a bath temperature of 50 ° C. to give 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (yield 85%) was obtained (HPLC purity (HPLC analysis condition 2)): 99 .7%).
実施例4
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド15.9g(0.078mol)、トリフルオロメタンスルホン酸イッテルビウム(III)水和物1.2g(2.5mol%)およびアセトニトリル150.0gを混合し、30℃で48時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール17.7g(0.109mol)を加え、75℃で3時間撹拌した。冷却後、反応混合物を減圧下で濃縮し、アセトニトリルを130g留去した。続いて、50℃でメタノール180.0gを添加し、0.5時間撹拌した後、0℃に冷却して、8時間撹拌した後、析出した結晶を濾過により単離した。得られた結晶をメタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン28.9g(収率88%)を得た(HPLC純度(HPLC分析条件2):99.7%)。
Example 4
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 15.0 g (0.078 mol) 4- (4-aminophenyl) morpholin-3-one, 15.9 g (0.078 mol) (S) -N-glycidylphthalimide, trifluoromethanesulfone 1.2 g (2.5 mol%) of ytterbium (III) acid hydrate and 150.0 g of acetonitrile were mixed and stirred at 30 ° C. for 48 hours. To the obtained mixture, 17.7 g (0.109 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 3 hours. After cooling, the reaction mixture was concentrated under reduced pressure, and 130 g of acetonitrile was distilled off. Subsequently, 180.0 g of methanol was added at 50 ° C. and stirred for 0.5 hour, then cooled to 0 ° C. and stirred for 8 hours, and then the precipitated crystals were isolated by filtration. The obtained crystals were washed with methanol and then dried under reduced pressure at a bath temperature of 50 ° C. to give 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (yield 88%) was obtained (HPLC purity (HPLC analysis condition 2)): 99 .7%).
実施例5
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド5.3g(0.026mol)、トリフルオロメタンスルホン酸イッテルビウム(III)水和物1.2g(2.5mol%)およびアセトニトリル105.0gを混合し、30℃で5時間撹拌した。次いで(S)-N-グリシジルフタルイミド 5.3g(0.026mol)を添加し、30℃で5時間撹拌した後、さらに(S)-N-グリシジルフタルイミド5.3g(0.026mol)を添加し、30℃で20時間撹拌した。同温度で得られた混合物に1,1’-カルボニルジイミダゾール14.6g(0.090mol)を加え、75℃で1時間撹拌した。50℃に冷却後、反応混合物を減圧下で濃縮し、アセトニトリル75gを留去した。次いで、50℃でトルエン180.0gを添加し、0.5時間撹拌した後、0℃に冷却して析出した固体を濾過により単離した。得られた固体をトルエンで洗浄後、浴温50℃の減圧下で乾燥させ、粗2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンを得た。得られた粗2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン、トルエン150.0gおよびエタノール15.0gを混合し、25℃で1時間撹拌した後、さらに、0℃に冷却して8時間撹拌し、析出した結晶を濾過により単離した。得られた結晶をトルエンで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン30.5g(収率93%)を得た(HPLC純度(HPLC分析条件2):99.6%)。
Example 5
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 4- (4-aminophenyl) morpholin-3-one 15.0 g (0.078 mol), (S) -N-glycidylphthalimide 5.3 g (0.026 mol), trifluoromethanesulfone 1.2 g (2.5 mol%) of ytterbium (III) acid hydrate and 105.0 g of acetonitrile were mixed and stirred at 30 ° C. for 5 hours. Next, 5.3 g (0.026 mol) of (S) —N-glycidylphthalimide was added and stirred at 30 ° C. for 5 hours, and then 5.3 g (0.026 mol) of (S) —N-glycidylphthalimide was further added. And stirred at 30 ° C. for 20 hours. To the mixture obtained at the same temperature, 14.6 g (0.090 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 1 hour. After cooling to 50 ° C., the reaction mixture was concentrated under reduced pressure, and 75 g of acetonitrile was distilled off. Next, 180.0 g of toluene was added at 50 ° C., and the mixture was stirred for 0.5 hour, then cooled to 0 ° C. and the precipitated solid was isolated by filtration. The obtained solid was washed with toluene, dried under reduced pressure at a bath temperature of 50 ° C., and crude 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl ] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione was obtained. The resulting crude 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-iso Indole-1,3 (2H) -dione, 150.0 g of toluene and 15.0 g of ethanol were mixed and stirred at 25 ° C. for 1 hour, further cooled to 0 ° C. and stirred for 8 hours. Isolated by filtration. The obtained crystals were washed with toluene, dried under reduced pressure at a bath temperature of 50 ° C., and 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (yield 93%) was obtained (HPLC purity (HPLC analysis condition 2)): 99 .6%).
実施例6
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン15.0g(0.078mol)、(S)-N-グリシジルフタルイミド15.9g(0.078mol)、トリフルオロメタンスルホン酸亜鉛(II)1.4g(5mol%)およびアセトニトリル200.3gを混合し、40℃で28時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール17.08g(0.105mol)を加え、75℃で2.5時間撹拌した。50℃に冷却後、反応混合物を減圧下で濃縮し、アセトニトリル170gを留去した。次いで、50℃でメタノール180.0gを添加し、0.5時間撹拌した後、さらに、0℃に冷却して8時間撹拌し、析出した結晶を濾過により単離した。得られた結晶をメタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン28.1g(収率86%)を得た(HPLC純度(HPLC分析条件2):99.5%)。
Example 6
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 15.0 g (0.078 mol) 4- (4-aminophenyl) morpholin-3-one, 15.9 g (0.078 mol) (S) -N-glycidylphthalimide, trifluoromethanesulfone Zinc (II) acid (1.4 g, 5 mol%) and acetonitrile (200.3 g) were mixed and stirred at 40 ° C. for 28 hours. To the resulting mixture, 17.08 g (0.105 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2.5 hours. After cooling to 50 ° C., the reaction mixture was concentrated under reduced pressure, and 170 g of acetonitrile was distilled off. Next, 180.0 g of methanol was added at 50 ° C., and the mixture was stirred for 0.5 hour, further cooled to 0 ° C. and stirred for 8 hours, and the precipitated crystals were isolated by filtration. The obtained crystals were washed with methanol and then dried under reduced pressure at a bath temperature of 50 ° C. to give 2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (yield 86%) (HPLC purity (HPLC analysis condition 2)): 99 .5%).
実施例7
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩の合成
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン30.0g(0.071mol)とアセトニトリル177.6gとの混合物に、25℃でメチルアミン水溶液(40%)24.3g(0.313mol)を滴下した。次いで60℃に加熱し、4時間撹拌した。得られた混合物にイソプロピルアルコール36.0gを加え、55℃に冷却後、20%塩酸46.0gをpHが1.5になるまで滴下し、0.5時間撹拌した。その後、20℃に冷却して、13.5時間撹拌した後、析出した結晶を濾過により単離した。得られた結晶を90%アセトニトリル水溶液、次いでアセトニトリルで洗浄後、浴温50℃の減圧下で乾燥させ、4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩18.1g(収率77.6%)を得た(HPLC純度(HPLC分析条件2):99.8%)。
Example 7
Synthesis of 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 2-({(5S)- 2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidin-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione30. To a mixture of 0 g (0.071 mol) and 177.6 g of acetonitrile, 24.3 g (0.313 mol) of an aqueous methylamine solution (40%) was added dropwise at 25 ° C. Subsequently, it heated at 60 degreeC and stirred for 4 hours. 36.0 g of isopropyl alcohol was added to the obtained mixture, and after cooling to 55 ° C., 46.0 g of 20% hydrochloric acid was added dropwise until the pH reached 1.5, followed by stirring for 0.5 hour. Then, after cooling to 20 ° C. and stirring for 13.5 hours, the precipitated crystals were isolated by filtration. The obtained crystals were washed with 90% acetonitrile aqueous solution and then with acetonitrile, and then dried under reduced pressure at a bath temperature of 50 ° C. to give 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1, 18.1 g (yield 77.6%) of 3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride was obtained (HPLC purity (HPLC analysis condition 2): 99.8%).
参考例1
5-クロロチオフェン-2-カルボニルクロリドの合成
5-クロロチオフェン-2-カルボン酸12.4g(0.076mol)とN,N-ジメチルホルムアミド0.1g(1.779mmol)との混合物にトルエン32.4gを加え、60℃に加熱した。60℃で塩化チオニル9.1g(0.076mol)を3時間かけて滴下し、6時間撹拌した。室温に冷却後、反応混合物を浴温60℃以下の減圧下で濃縮し、約40%以上の5-クロロチオフェン-2-カルボニルクロリドのトルエン溶液が得られるまで塩化チオニルとトルエンを留去した(トルエンの濃度はガスクロマトグラフィーにて確認した。)。冷却後、トルエンを添加して約35%の5-クロロチオフェン-2-カルボニルクロリドのトルエン溶液39.5gを得た。
Reference example 1
Synthesis of 5-chlorothiophene-2-carbonyl chloride To a mixture of 12.4 g (0.076 mol) of 5-chlorothiophene-2-carboxylic acid and 0.1 g (1.779 mmol) of N, N-dimethylformamide in toluene 32. 4 g was added and heated to 60 ° C. At 60 ° C., 9.1 g (0.076 mol) of thionyl chloride was added dropwise over 3 hours and stirred for 6 hours. After cooling to room temperature, the reaction mixture was concentrated under reduced pressure with a bath temperature of 60 ° C. or less, and thionyl chloride and toluene were distilled off until a toluene solution of about 40% or more of 5-chlorothiophene-2-carbonyl chloride was obtained ( The concentration of toluene was confirmed by gas chromatography.) After cooling, toluene was added to obtain 39.5 g of a toluene solution of about 35% 5-chlorothiophene-2-carbonyl chloride.
実施例8
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの合成
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩15.0g(0.046mol)、水10.5gおよびアセトニトリル75.0gを室温で混合し、25℃でトリエチルアミン11.6g(0.114mol)を滴下した。10℃に冷却後、10℃で約35%濃度の5-クロロチオフェン-2-カルボニルクロリドのトルエン溶液29.6g(0.057mol)およびトルエン4.8gを滴下し、20℃に加熱した後、2時間撹拌した。次いで、得られた混合物を50℃に加熱し、3時間撹拌した後、25℃に冷却して11.5時間撹拌し、析出した結晶を濾過により単離した。得られた結晶をアセトニトリルおよび水で順次洗浄後、浴温50℃の減圧下で乾燥させ、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド18.5g(収率93%)を得た(HPLC純度(HPLC分析条件2):99.96%以上)。
Example 8
5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2- Synthesis of carboxamide 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 15.0 g (0.046 mol) ), 10.5 g of water and 75.0 g of acetonitrile were mixed at room temperature, and 11.6 g (0.114 mol) of triethylamine was added dropwise at 25 ° C. After cooling to 10 ° C., 29.6 g (0.057 mol) of a toluene solution of about 35% concentration of 5-chlorothiophene-2-carbonyl chloride and 4.8 g of toluene were added dropwise at 10 ° C. and heated to 20 ° C. Stir for 2 hours. The resulting mixture was then heated to 50 ° C. and stirred for 3 hours, then cooled to 25 ° C. and stirred for 11.5 hours, and the precipitated crystals were isolated by filtration. The obtained crystals were washed successively with acetonitrile and water and then dried under reduced pressure at a bath temperature of 50 ° C. to give 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholine -4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide (18.5 g, yield 93%) was obtained (HPLC purity (HPLC analysis condition 2): 99.96. %that's all).
参考例2
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの再結晶
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド15.0g(0.034mol)に、ジメチルスルホキシド(以下、DMSOと記す。)60.0gを加え、70℃に加熱し、活性炭0.5gを添加して0.5時間撹拌した。次いで濾過して得た固体をDMSO22.5gで洗浄し、濾液と洗浄液との混合液を得た。得られた混合液に50℃でメタノール82.5gをゆっくり滴下した後、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの結晶0.02gを添加した。その後、5℃に冷却し、14時間撹拌して析出した結晶を濾過した。得られた結晶をメタノールおよび水で順次洗浄後、浴温50℃の減圧下で乾燥させ、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド14.2g(収率94%)を得た(HPLC純度(HPLC分析条件2):99.96%以上、光学純度(HPLC分析条件1):99.99%以上)。
Reference example 2
5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2- Recrystallization of carboxamide 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) 60.0 g of dimethyl sulfoxide (hereinafter referred to as DMSO) is added to 15.0 g (0.034 mol) of thiophene-2-carboxamide, heated to 70 ° C., 0.5 g of activated carbon is added, and the mixture is stirred for 0.5 hours. did. Subsequently, the solid obtained by filtration was washed with 22.5 g of DMSO to obtain a mixed solution of the filtrate and the washing solution. After 82.5 g of methanol was slowly added dropwise at 50 ° C. to the resulting mixture, 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) 0.02 g of crystals of [phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide were added. Then, it cooled to 5 degreeC and stirred for 14 hours, and the precipitated crystal | crystallization was filtered. The obtained crystals were washed successively with methanol and water and then dried under reduced pressure at a bath temperature of 50 ° C. to give 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholine -4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide (14.2 g, yield 94%) was obtained (HPLC purity (HPLC analysis condition 2): 99.96. % Or more, optical purity (HPLC analysis condition 1): 99.99% or more).
参考例3
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの再結晶
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド31.0g(0.071mol)に、DMSO124.0gを加え、70℃に加熱し、活性炭0.9gを添加して0.5時間撹拌した。次いで、濾過して得た固体をDMSO46.5gで洗浄し、濾液と洗浄液との混合液を得た。
得られた混合液94.7g(5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド0.034mol相当を含む)に50℃でメタノール4.2gをゆっくり滴下した後、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの結晶0.02gを添加し、4時間撹拌した。その後、50℃でメタノール78.3gをゆっくり滴下し、5℃に冷却し、10.5時間撹拌して析出した結晶を濾過した。得られた結晶をメタノールおよび水で順次洗浄後、浴温50℃の減圧下で乾燥させ、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド14.2g(収率95%)を得た(HPLC純度(HPLC分析条件2):99.96%以上、光学純度(HPLC分析条件1):99.99%以上)。
得られた結晶を近赤外(NIR)分析法により分析した結果、特許第5416408号公報記載の5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの変態Iと一致した。
Reference example 3
5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2- Recrystallization of carboxamide 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) To 31.0 g (0.071 mol) of thiophene-2-carboxamide, 124.0 g of DMSO was added, heated to 70 ° C., 0.9 g of activated carbon was added, and the mixture was stirred for 0.5 hours. Subsequently, the solid obtained by filtration was washed with 46.5 g of DMSO to obtain a mixed solution of the filtrate and the washing solution.
94.7 g of the obtained mixed solution (5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5 -Yl} methyl) thiophene-2-carboxamide (containing 0.034 mol equivalent) at 50 ° C. was slowly added dropwise with 4.2 g of methanol, and then 5-chloro-N-({(5S) -2-oxo-3- [ 0.02 g of 4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide crystal was added and stirred for 4 hours. Thereafter, 78.3 g of methanol was slowly added dropwise at 50 ° C., cooled to 5 ° C., stirred for 10.5 hours, and the precipitated crystals were filtered. The obtained crystals were washed successively with methanol and water and then dried under reduced pressure at a bath temperature of 50 ° C. to give 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholine -4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide (14.2 g, yield 95%) was obtained (HPLC purity (HPLC analysis condition 2): 99.96. % Or more, optical purity (HPLC analysis condition 1): 99.99% or more).
As a result of analyzing the obtained crystal by a near infrared (NIR) analysis method, it was found that 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxo Consistent with modification I of morpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide.
実施例9
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩の合成
4-(4-アミノフェニル)モルホリン-3-オン20.0g(0.104mol)、(S)-N-グリシジルフタルイミド21.1g(0.104mol)、トリフルオロメタンスルホン酸亜鉛(II)1.9g(5mol%)およびアセトニトリル267.0gを混合し、45℃で18時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール19.4g(0.120mol)を加え、75℃で2時間撹拌した。25℃に冷却後、25℃でメチルアミン水溶液(40%)35.4g(0.458mol)を滴下した。次いで60℃に加熱し、4時間撹拌して得られた混合物にアセトニトリル13.2gおよびイソプロピルアルコール52.6gを加え、55℃に冷却後、20%塩酸110.9gをpHが2.0になるまで滴下し、0.5時間撹拌した。その後、20℃に冷却し、11時間撹拌して析出した結晶を濾過により単離した。得られた結晶を90%アセトニトリル水溶液、次いでアセトニトリルで洗浄後、浴温50℃の減圧下で乾燥させ、4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩19.1g(収率56.1%)を得た(HPLC純度(HPLC分析条件2):99.8%)。
Example 9
Synthesis of 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 4- (4-aminophenyl) 20.0 g (0.104 mol) of morpholin-3-one, 21.1 g (0.104 mol) of (S) —N-glycidylphthalimide, 1.9 g (5 mol%) of zinc (II) trifluoromethanesulfonate, and 267. 0 g was mixed and stirred at 45 ° C. for 18 hours. To the obtained mixture, 19.4 g (0.120 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2 hours. After cooling to 25 ° C., 35.4 g (0.458 mol) of an aqueous methylamine solution (40%) was added dropwise at 25 ° C. Next, the mixture was heated to 60 ° C. and stirred for 4 hours. Then, 13.2 g of acetonitrile and 52.6 g of isopropyl alcohol were added. After cooling to 55 ° C., 110.9 g of 20% hydrochloric acid was adjusted to pH 2.0. And stirred for 0.5 hour. Then, it cooled to 20 degreeC, stirred for 11 hours, and isolate | separated the crystal | crystallization which precipitated. The obtained crystals were washed with 90% acetonitrile aqueous solution and then with acetonitrile, and then dried under reduced pressure at a bath temperature of 50 ° C. to give 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1, 19.1 g (yield 56.1%) of 3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride was obtained (HPLC purity (HPLC analysis condition 2): 99.8%).
実施例10
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩の合成
4-(4-アミノフェニル)モルホリン-3-オン40.0g(0.208mol)、(S)-N-グリシジルフタルイミド42.3g(0.208mol)、トリフルオロメタンスルホン酸亜鉛(II)3.8g(5mol%)およびアセトニトリル534.0gを混合し、45℃で17時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール38.8g(0.239mol)を加え、75℃で2時間撹拌した。25℃に冷却後、25℃でメチルアミン水溶液(40%)70.7g(0.915mol)を滴下した。次いで、60℃に加熱し、4時間撹拌した。得られた混合物にアセトニトリル12.0gおよびイソプロピルアルコール48.0gを加え、55℃に冷却後、35%塩酸128.6gをpHが1.8になるまで滴下し、0.5時間撹拌した。その後、20℃に冷却し、11.5時間撹拌して析出した結晶を濾過により単離した。得られた結晶を90%アセトニトリル水溶液、次いでアセトニトリルで洗浄後、浴温50℃の減圧下で乾燥させ、4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩51.3g(収率74.3%)を得た(HPLC純度(HPLC分析条件2):97.7%)。
Example 10
Synthesis of 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 4- (4-aminophenyl) 40.0 g (0.208 mol) of morpholin-3-one, 42.3 g (0.208 mol) of (S) —N-glycidylphthalimide, 3.8 g (5 mol%) of zinc (II) trifluoromethanesulfonate, and 534. 0 g was mixed and stirred at 45 ° C. for 17 hours. To the obtained mixture, 38.8 g (0.239 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2 hours. After cooling to 25 ° C., 70.7 g (0.915 mol) of an aqueous methylamine solution (40%) was added dropwise at 25 ° C. Subsequently, it heated at 60 degreeC and stirred for 4 hours. 12.0 g of acetonitrile and 48.0 g of isopropyl alcohol were added to the obtained mixture, and after cooling to 55 ° C., 128.6 g of 35% hydrochloric acid was added dropwise until the pH reached 1.8, followed by stirring for 0.5 hours. Then, it cooled to 20 degreeC and stirred for 11.5 hours, and the crystal | crystallization which precipitated was isolated by filtration. The obtained crystals were washed with 90% acetonitrile aqueous solution and then with acetonitrile, and then dried under reduced pressure at a bath temperature of 50 ° C. to give 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1, There was obtained 51.3 g (yield 74.3%) of 3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride (HPLC purity (HPLC analysis condition 2): 97.7%).
実施例11
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン 8.0g(0.042mol)、(S)-N-グリシジルフタルイミド 8.5g(0.042mol)、トリフルオロメタンスルホン酸アルミニウム(III)0.7g(3.5mol%)およびアセトニトリル80.0gを混合し、40℃で21時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール7.8g(0.048mol)を加え、75℃で1.5時間撹拌した。50℃でメタノール 40.0gを滴下し、20℃に冷却し、1時間撹拌して得られた結晶を濾過により単離し、メタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン13.0g(収率74%)を得た(HPLC純度(HPLC分析条件2):99.9%)。
Example 11
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 4- (4-aminophenyl) morpholin-3-one 8.0 g (0.042 mol), (S) -N-glycidylphthalimide 8.5 g (0.042 mol), trifluoromethanesulfone 0.7 g (3.5 mol%) of aluminum (III) acid and 80.0 g of acetonitrile were mixed and stirred at 40 ° C. for 21 hours. To the obtained mixture, 7.8 g (0.048 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 1.5 hours. 40.0 g of methanol was added dropwise at 50 ° C., cooled to 20 ° C., stirred for 1 hour, and the resulting crystals were isolated by filtration, washed with methanol, dried under reduced pressure at a bath temperature of 50 ° C., 2- ({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 ( 2H) -dione (13.0 g, yield 74%) was obtained (HPLC purity (HPLC analysis condition 2): 99.9%).
実施例12
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン20.0g(0.104mol)、(S)-N-グリシジルフタルイミド21.1g(0.104mol)、トリフルオロメタンスルホン酸亜鉛(II)1.0g(2.5mol%)およびアセトニトリル267.0gを混合し、50℃で23時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール19.4g(0.120mol)を加え、75℃で2時間撹拌した。得られた混合物にアセトニトリル13.0gを加え、50℃でメタノール 140.0gを滴下した。0℃に冷却し、6.5時間撹拌して得られた結晶を濾過により単離し、メタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン35.8g(収率82%)を得た(HPLC純度(HPLC分析条件2):99.7%)。
Example 12
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 2- (4-aminophenyl) morpholin-3-one 20.0 g (0.104 mol), (S) -N-glycidylphthalimide 21.1 g (0.104 mol), trifluoromethanesulfone A mixture of 1.0 g (2.5 mol%) of zinc acid (II) and 267.0 g of acetonitrile was stirred at 50 ° C. for 23 hours. To the obtained mixture, 19.4 g (0.120 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2 hours. Acetonitrile 13.0g was added to the obtained mixture, and methanol 140.0g was dripped at 50 degreeC. The crystals obtained after cooling to 0 ° C. and stirring for 6.5 hours were isolated by filtration, washed with methanol, dried under reduced pressure at a bath temperature of 50 ° C., and 2-({(5S) -2-oxo -3- [4- (3-Oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (35.8 g) 82%) (HPLC purity (HPLC analysis condition 2): 99.7%).
実施例13
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオンの合成
4-(4-アミノフェニル)モルホリン-3-オン40.0g(0.208mol)、(S)-N-グリシジルフタルイミド42.3g(0.208mol)、トリフルオロメタンスルホン酸亜鉛(II)3.8g(5mol%)およびアセトニトリル534.0gを混合し、45℃で17時間撹拌した。得られた混合物に1,1’-カルボニルジイミダゾール38.8g(0.239mol)を加え、75℃で2時間撹拌した。次いで、アセトニトリル26.0gを加え、50℃でメタノール 280.0gを滴下した。0℃に冷却し、12時間撹拌して得られた結晶を濾過により単離し、メタノールで洗浄後、浴温50℃の減圧下で乾燥させ、2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン71.1g(収率81%)を得た(HPLC純度(HPLC分析条件2):99.7%)。
Example 13
2-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1, Synthesis of 3 (2H) -dione 4- (4-aminophenyl) morpholin-3-one 40.0 g (0.208 mol), (S) -N-glycidylphthalimide 42.3 g (0.208 mol), trifluoromethanesulfone 3.8 g (5 mol%) of zinc (II) acid and 534.0 g of acetonitrile were mixed and stirred at 45 ° C. for 17 hours. To the obtained mixture, 38.8 g (0.239 mol) of 1,1′-carbonyldiimidazole was added and stirred at 75 ° C. for 2 hours. Next, 26.0 g of acetonitrile was added, and 280.0 g of methanol was added dropwise at 50 ° C. Crystals obtained by cooling to 0 ° C. and stirring for 12 hours were isolated by filtration, washed with methanol, dried under reduced pressure at a bath temperature of 50 ° C., and 2-({(5S) -2-oxo-3 71.1 g of-[4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione (yield 81 %) (HPLC purity (HPLC analysis condition 2): 99.7%).
実施例14
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩の合成
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン60.0g(0.142mol)とアセトニトリル337.2gとの混合物に、25℃でメチルアミン水溶液(40%)48.7g(0.626mol)を滴下した。次いで、60℃に加熱し、4時間撹拌した。得られた混合物にアセトニトリル30.0gおよびイソプロピルアルコール72.0gを加え、55℃に冷却後、35%塩酸54.0gをpHが1.7になるまで滴下し、0.5時間撹拌した。その後、0℃に冷却し、9.5時間撹拌して得られた結晶を濾過により単離し、90%アセトニトリル水溶液、次いでアセトニトリルで洗浄後、浴温50℃の減圧下で乾燥させ、4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩43.5g(収率93.0%)を得た(HPLC純度(HPLC分析条件2):98.2%)。
Example 14
Synthesis of 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 2-({(5S)- 2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidin-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione To a mixture of 0 g (0.142 mol) and 337.2 g of acetonitrile, 48.7 g (0.626 mol) of an aqueous methylamine solution (40%) was added dropwise at 25 ° C. Subsequently, it heated at 60 degreeC and stirred for 4 hours. 30.0 g of acetonitrile and 72.0 g of isopropyl alcohol were added to the obtained mixture, and after cooling to 55 ° C., 54.0 g of 35% hydrochloric acid was added dropwise until the pH reached 1.7, followed by stirring for 0.5 hours. Thereafter, the crystal obtained by cooling to 0 ° C. and stirring for 9.5 hours is isolated by filtration, washed with 90% acetonitrile aqueous solution and then with acetonitrile, dried under reduced pressure at a bath temperature of 50 ° C., and 4- { 43.5 g (yield 93.0%) of 4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride was obtained. (HPLC purity (HPLC analysis condition 2): 98.2%).
実施例15
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩の合成
2-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)-1H-イソインドール-1,3(2H)-ジオン30.0g(0.071mol)とアセトニトリル168.6gとの混合物に、25℃でメチルアミン水溶液(40%)24.2g(0.313mol)を滴下した。次いで、60℃に加熱し、4時間撹拌した。得られた混合物にアセトニトリル9.0gおよびメタノール36.0gを加え、55℃に冷却後、35%塩酸28.5gをpHが1.6になるまで滴下し、0.5時間撹拌した。その後、0℃に冷却し、14.5時間撹拌して得られた結晶を濾過により単離し、90%アセトニトリル水溶液、次いでアセトニトリルで洗浄後、浴温50℃の減圧下で乾燥させ、4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩20.2g(収率86.5%)を得た(HPLC純度(HPLC分析条件2):99.6%)。
Example 15
Synthesis of 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 2-({(5S)- 2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidin-5-yl} methyl) -1H-isoindole-1,3 (2H) -dione30. To a mixture of 0 g (0.071 mol) and 168.6 g of acetonitrile, 24.2 g (0.313 mol) of an aqueous methylamine solution (40%) was added dropwise at 25 ° C. Subsequently, it heated at 60 degreeC and stirred for 4 hours. To the obtained mixture, 9.0 g of acetonitrile and 36.0 g of methanol were added. After cooling to 55 ° C., 28.5 g of 35% hydrochloric acid was added dropwise until the pH reached 1.6, followed by stirring for 0.5 hours. After cooling to 0 ° C. and stirring for 14.5 hours, the crystals obtained were isolated by filtration, washed with 90% acetonitrile aqueous solution and then with acetonitrile, and then dried under reduced pressure at a bath temperature of 50 ° C. There was obtained 20.2 g (yield 86.5%) of 4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride. (HPLC purity (HPLC analysis condition 2): 99.6%).
実施例16
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの合成
4-{4-[(5S)-5-(アミノメチル)-2-オキソ-1,3-オキサゾリジン-3-イル]フェニル}モルホリン-3-オン塩酸塩15.0g(0.046mol)、水10.5gおよびアセトニトリル75.0gを室温で混合し、25℃でトリエチルアミン12.2g(0.120mol)を滴下した。10℃に冷却後、10℃で約35%濃度の5-クロロチオフェン-2-カルボニルクロリドのトルエン溶液32.0g(0.062mol)およびトルエン4.8gを滴下し、20℃に加熱した後、2時間撹拌した。次いで、得られた混合物を50℃に加熱し、2時間撹拌した後、アセトニトリル10.5gを加え、0℃に冷却し、11時間撹拌して得られた結晶を濾過により単離し、アセトニトリルおよび水で順次洗浄後、浴温50℃の減圧下で乾燥させ、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド18.0g(収率90%)を得た(HPLC純度(HPLC分析条件2):99.95%以上)。
Example 16
5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2- Synthesis of carboxamide 4- {4-[(5S) -5- (aminomethyl) -2-oxo-1,3-oxazolidin-3-yl] phenyl} morpholin-3-one hydrochloride 15.0 g (0.046 mol) ), 10.5 g of water and 75.0 g of acetonitrile were mixed at room temperature, and 12.2 g (0.120 mol) of triethylamine was added dropwise at 25 ° C. After cooling to 10 ° C., 32.0 g (0.062 mol) of a toluene solution of 5-chlorothiophene-2-carbonyl chloride having a concentration of about 35% at 10 ° C. and 4.8 g of toluene were added dropwise and heated to 20 ° C. Stir for 2 hours. The resulting mixture was then heated to 50 ° C. and stirred for 2 hours, after which 10.5 g of acetonitrile was added, cooled to 0 ° C. and stirred for 11 hours, and the resulting crystals were isolated by filtration, acetonitrile and water And then dried under reduced pressure at a bath temperature of 50 ° C. to give 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl]- 18.0 g (90% yield) of 1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide was obtained (HPLC purity (HPLC analysis condition 2): 99.95% or more).
参考例4
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの再結晶
5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド15.0g(0.034mol)に、ジメチルスルホキシド(以下、DMSOと記す。)67.5gを加え、60℃に加熱し、活性炭0.5gを添加して、70℃に加熱し、0.5時間撹拌した。次いで濾過により分離された固体をDMSO10.5gで洗浄し、濾液と洗浄液との混合液を得た。得られた混合液およびDMSO4.5gを45℃で、メタノール82.5gおよび5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミドの結晶0.02gの混合物にゆっくり滴下した後、60℃に加熱し、2時間撹拌した。その後、5℃に冷却し9.5時間撹拌して析出した結晶を濾過した。得られた結晶をメタノールおよび水で順次洗浄後、浴温50℃の減圧下で乾燥させ、5-クロロ-N-({(5S)-2-オキソ-3-[4-(3-オキソモルホリン-4-イル)フェニル]-1,3-オキサゾリジン-5-イル}メチル)チオフェン-2-カルボキサミド14.3g(収率95%)を得た(HPLC純度(HPLC分析条件2):99.97%以上、光学純度(HPLC分析条件1):99.99%以上)。
Reference example 4
5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2- Recrystallization of carboxamide 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) 67.5 g of dimethyl sulfoxide (hereinafter referred to as DMSO) is added to 15.0 g (0.034 mol) of thiophene-2-carboxamide, heated to 60 ° C., 0.5 g of activated carbon is added, and heated to 70 ° C. And stirred for 0.5 hour. Next, the solid separated by filtration was washed with 10.5 g of DMSO to obtain a mixed solution of the filtrate and the washing solution. The resulting mixture and 4.5 g DMSO at 45 ° C., 82.5 g methanol and 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholin-4-yl) Phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide was slowly added dropwise to a mixture of 0.02 g of crystals, heated to 60 ° C., and stirred for 2 hours. Then, it cooled to 5 degreeC and stirred for 9.5 hours, and the precipitated crystal | crystallization was filtered. The obtained crystals were washed successively with methanol and water and then dried under reduced pressure at a bath temperature of 50 ° C. to give 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxomorpholine -4-yl) phenyl] -1,3-oxazolidine-5-yl} methyl) thiophene-2-carboxamide (14.3 g, yield 95%) was obtained (HPLC purity (HPLC analysis condition 2): 99.97. % Or more, optical purity (HPLC analysis condition 1): 99.99% or more).
本発明により、医薬品として有用なリバーロキサバンの製造中間体である化合物(3)および化合物(4)の塩酸塩、ならびにリバーロキサバンを効率よく製造することができる。 According to the present invention, the hydrochloride of compound (3) and compound (4), which are production intermediates of rivaroxaban useful as a pharmaceutical, and rivaroxaban can be efficiently produced.
Claims (6)
で表される化合物の製造方法:
工程1:アセトニトリル中、式(1)
で表される化合物と式(2)
で表される化合物とをトリフルオロメタンスルホナートの存在下で反応させる工程;
工程2:工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させ、式(3)で表される化合物を得る工程。 Formula (3) including Step 1 and Step 2
A method for producing a compound represented by:
Step 1: Formula (1) in acetonitrile
And a compound represented by formula (2)
A step of reacting a compound represented by formula (II) in the presence of trifluoromethanesulfonate;
Step 2: A step of reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole to obtain a compound represented by Formula (3).
で表される化合物の塩酸塩の製造方法:
工程3:式(3)で表される化合物とメチルアミンとを反応させて、式(4)で表される化合物を得る工程;
工程4:式(4)で表される化合物と塩化水素とを反応させて、式(4)で表される化合物の塩酸塩を得る工程。 Formula (4) including step 3 and step 4 in addition to step 1 and step 2 according to claim 1
A method for producing a hydrochloride salt of a compound represented by:
Step 3: A step of obtaining a compound represented by Formula (4) by reacting a compound represented by Formula (3) with methylamine;
Process 4: The process of obtaining the hydrochloride of the compound represented by Formula (4) by making the compound represented by Formula (4) and hydrogen chloride react.
で表される化合物の塩酸塩の製造方法:
工程1:アセトニトリル中、式(1)
で表される化合物と式(2)
で表される化合物とをトリフルオロメタンスルホナートの存在下で反応させる工程;
工程2’:工程1で得られた混合物と1,1’-カルボニルジイミダゾールとを反応させる工程;
工程3’:工程2’で得られた混合物とメチルアミンとを反応させて、式(4)で表される化合物を得る工程;
工程4:式(4)で表される化合物と塩化水素とを反応させて、式(4)で表される化合物の塩酸塩を得る工程。 Formula (4) including Step 1, Step 2 ′, Step 3 ′ and Step 4
A method for producing a hydrochloride salt of a compound represented by:
Step 1: Formula (1) in acetonitrile
And a compound represented by formula (2)
A step of reacting a compound represented by formula (II) in the presence of trifluoromethanesulfonate;
Step 2 ′: reacting the mixture obtained in Step 1 with 1,1′-carbonyldiimidazole;
Step 3 ′: reacting the mixture obtained in Step 2 ′ with methylamine to obtain a compound represented by Formula (4);
Process 4: The process of obtaining the hydrochloride of the compound represented by Formula (4) by making the compound represented by Formula (4) and hydrogen chloride react.
で表される化合物の塩酸塩の製造方法、および工程5を含む式(6)
で表される化合物の製造方法:
工程5:式(4)で表される化合物の塩酸塩と式(5)
で表される化合物とを塩基の存在下で反応させて、式(6)で表される化合物を得る工程。 Formula (4) according to claim 2
And a process for producing a hydrochloride salt of the compound represented by formula (6):
A method for producing a compound represented by:
Step 5: Hydrochloride of the compound represented by the formula (4) and the formula (5)
A step of reacting the compound represented by formula (6) in the presence of a base to obtain the compound represented by formula (6).
で表される化合物の塩酸塩の製造方法、および工程5を含む式(6)
で表される化合物の製造方法:
工程5:式(4)で表される化合物の塩酸塩と式(5)
で表される化合物とを塩基の存在下で反応させて、式(6)で表される化合物を得る工程。 Formula (4) according to claim 3
And a process for producing a hydrochloride salt of the compound represented by formula (6):
A method for producing a compound represented by:
Step 5: Hydrochloride of the compound represented by the formula (4) and the formula (5)
A step of reacting the compound represented by formula (6) in the presence of a base to obtain the compound represented by formula (6).
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL275443A IL275443B (en) | 2018-02-26 | 2019-02-19 | Production method for an oxazolidinan compound |
| CN201980012405.8A CN111699184B (en) | 2018-02-26 | 2019-02-19 | Process for producing oxazolidinone compound |
| JP2020501763A JP7205529B2 (en) | 2018-02-26 | 2019-02-19 | Method for producing oxazolidinone compound |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018031603 | 2018-02-26 | ||
| JP2018-031603 | 2018-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019163731A1 true WO2019163731A1 (en) | 2019-08-29 |
Family
ID=67687660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2019/005969 Ceased WO2019163731A1 (en) | 2018-02-26 | 2019-02-19 | Production method for oxazolidinone compound |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP7205529B2 (en) |
| CN (1) | CN111699184B (en) |
| IL (1) | IL275443B (en) |
| TW (1) | TW201936603A (en) |
| WO (1) | WO2019163731A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020158443A (en) * | 2019-03-27 | 2020-10-01 | ダイト株式会社 | Method for producing intermediate |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111039937B (en) * | 2019-12-16 | 2021-08-31 | 浙江海翔药业股份有限公司 | Preparation method of rivaroxaban intermediate |
| CN115490678B (en) * | 2022-10-24 | 2025-02-18 | 浙江苏泊尔制药有限公司 | Preparation method of high-purity rivaroxaban |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005524660A (en) * | 2002-02-25 | 2005-08-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterial agents |
| JP2007517816A (en) * | 2004-01-15 | 2007-07-05 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Production method |
| JP2010530385A (en) * | 2007-06-20 | 2010-09-09 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | Substituted oxazolidinones and their use |
| CN104031036A (en) * | 2014-05-16 | 2014-09-10 | 南通常佑药业科技有限公司 | Method for preparing rivaroxaban |
| WO2014155259A2 (en) * | 2013-03-25 | 2014-10-02 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for the preparation of rivaroxaban |
| US20150038704A1 (en) * | 2012-02-24 | 2015-02-05 | China National Medicines Guorui Pharmaceutical Co. | Method for preparing rivaroxaban intermediate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016199027A1 (en) * | 2015-06-08 | 2016-12-15 | Mehta Api Pvt. Ltd. | An improved process for preparation of rivaroxaban |
| IN201641035583A (en) * | 2016-10-18 | 2016-12-30 | Divi's Laboratories Ltd |
-
2019
- 2019-02-19 IL IL275443A patent/IL275443B/en unknown
- 2019-02-19 WO PCT/JP2019/005969 patent/WO2019163731A1/en not_active Ceased
- 2019-02-19 CN CN201980012405.8A patent/CN111699184B/en active Active
- 2019-02-19 JP JP2020501763A patent/JP7205529B2/en active Active
- 2019-02-21 TW TW108105843A patent/TW201936603A/en unknown
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005524660A (en) * | 2002-02-25 | 2005-08-18 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterial agents |
| JP2007517816A (en) * | 2004-01-15 | 2007-07-05 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Production method |
| JP2010530385A (en) * | 2007-06-20 | 2010-09-09 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | Substituted oxazolidinones and their use |
| US20150038704A1 (en) * | 2012-02-24 | 2015-02-05 | China National Medicines Guorui Pharmaceutical Co. | Method for preparing rivaroxaban intermediate |
| WO2014155259A2 (en) * | 2013-03-25 | 2014-10-02 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for the preparation of rivaroxaban |
| CN104031036A (en) * | 2014-05-16 | 2014-09-10 | 南通常佑药业科技有限公司 | Method for preparing rivaroxaban |
Non-Patent Citations (1)
| Title |
|---|
| FATTAH, TANZEELA A. ET AL.: "A review on the synthetic approaches of rivaroxaban: An anticoagulant drug", TETRAHEDRON : ASYMMETRY, vol. 28, no. 4, 2017, pages 485 - 504, XP085010267, doi:10.1016/j.tetasy.2017.02.010 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020158443A (en) * | 2019-03-27 | 2020-10-01 | ダイト株式会社 | Method for producing intermediate |
| JP7339754B2 (en) | 2019-03-27 | 2023-09-06 | ダイト株式会社 | Method for producing intermediates |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7205529B2 (en) | 2023-01-17 |
| CN111699184A (en) | 2020-09-22 |
| CN111699184B (en) | 2023-05-23 |
| IL275443B (en) | 2022-07-01 |
| IL275443A (en) | 2020-08-31 |
| JPWO2019163731A1 (en) | 2021-02-04 |
| TW201936603A (en) | 2019-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110650957B (en) | 5-Methyl-1,3,4-oxadiazol-2-yl compound | |
| CA2583660C (en) | Indoline compound and process for producing the same | |
| US10626091B2 (en) | Process for the preparation of enzalutamide | |
| JP7205529B2 (en) | Method for producing oxazolidinone compound | |
| WO2014017516A1 (en) | Method of producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazole-3-yl]pyridin-2-carbonitrile, and intermediary thereof | |
| CN102137857A (en) | Process for the preparation of benzimidazol-2-ylpyrimidine derivatives | |
| CN118401528A (en) | GLP-1 agonist intermediate, preparation method thereof and application thereof in medicines | |
| CA2721576A1 (en) | Compound having npy y5 receptor antagonist activity | |
| CN1688588A (en) | Process and intermediates for the preparation of thienopyrrole derivatives | |
| CN110612291A (en) | Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives | |
| JP5747030B2 (en) | Process for producing levosimendan and intermediate used in the process | |
| TW201925211A (en) | Process for preparing benzothiophen-2yl boronate | |
| CN1910161A (en) | A New Crystalline Form of Type 1 11-β-Hydroxysterol Dehydrogenase Inhibitor | |
| CN107722007B (en) | Preparation method of apixaban impurity | |
| US10640465B2 (en) | Method for preparing phenylalanine compound | |
| CN107709318B (en) | Preparation method of orexin receptor antagonist receptor compound and its intermediate and crystal form | |
| CZ200720A3 (en) | Process for preparing montelukast | |
| WO2017004964A1 (en) | Preparation method of 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | |
| AU2014221468B2 (en) | Substituted (R)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-enecarboxylic acid (variants) and ester thereof, method for producing and using same | |
| KR101811123B1 (en) | Novel morpholine diphosphate salt, and method for manufacturing high purity rivaroxaban using same | |
| CN104140430B (en) | A method for the racemization of isomers | |
| US11414400B2 (en) | Method for preparing sulfonamides drugs | |
| KR20210046649A (en) | Bicyclic heteroaromatic ring derivatives | |
| JP4194856B2 (en) | 2-Phenyl-4- (1-naphthyl) imidazole | |
| CN109705118B (en) | Preparation method of tricyclic EGFR kinase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19757046 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2020501763 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 19757046 Country of ref document: EP Kind code of ref document: A1 |